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ABSTRACT
Nuclear transfer (NT) results in relatively low success rates and research has reported
substantial problems with the welfare of the cloned animals produced. Evidence suggests that
the use of a less differentiated donor cell, such as a stem cell, may lead to an increase in the
efficiency of the NT procedure. To this end, stem cell characteristics must be clearly defined in
order to isolate, identify and optimally culture potential donor cells. Stem cell characteristics
such as self-renewal and differentiation have not been identified in stem cells from porcine
adipose tissue, an easily attainable tissue resource. At this time, the phenotypic profile of cell
surface proteins and chromosomal stability of porcine adipose tissue-derived stem cells
(pASCs) through in vitro culture have not been described. In addition, research has not
identified epigenetic modifications in adult somatic mesenchymal stem cells (MSCs) from
porcine adipose tissue.
The objective of Project 1 was to develop a protocol for the isolation and culture of
pASCs and to determine stem cell-like characteristics. The objective of Project 2 was to
partially characterize the surface protein phenotype of undifferentiated porcine ASCs and to
determine the chromosomal stability through in vitro culture. Research has indicated that the
inefficiency of NT may be attributed to changes in DNA methylation and histone acetylation as a
result of the duration of somatic cell in vitro culture. The objective of Project 3 was to analyze
pASCs and compare them to fetal porcine fibroblasts (FPF) for gene expression profiles of
chromatin remodeling proteins, global methylation and acetylation patterns and methylated
lysine residues within promoter regions of developmentally important transcription factors.
Improved culture conditions and defined cellular characteristics of these pASCs have
been identified. pASCs can self-renew and differentiate into multiple tissue lineages. Porcine
ASCs do not express the stem cell surface markers analyzed at similar levels compared with
those of human ASCs reported in the literature. Also, in vitro-cultured porcine ASCs used as
donor cells for NT should be chosen from early population doublings (PDs) due to increased
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levels of aneuploidy at later PDs. Further characterization of porcine ASCs in this manner could
assist the isolation and purification of a population of MSCs from the easily obtainable tissue of
adipose that can later be tested as donor cells in nuclear transfer.
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CHAPTER I
INTRODUCTION
Currently, nuclear transfer (NT) results in relatively low success rates of approximately
1-2% (Hiendleder et al., 2005) and research has reported substantial problems with the health
and welfare of the cloned animals. Developmental abnormalities observed following NT define
Large Offspring Syndrome (LOS) and include low pregnancy rates, high percentages of loss
during early and late pregnancy, stillbirths, early postnatal deaths, short life-span, obesity and
malformations (Young et al., 2001). LOS may be caused by several factors such as using an
inappropriate donor cell and/or recipient oocyte, the inability to properly synchronize the cell
cycle phase of the donor nucleus and the recipient cytoplasm and inadequate reprogramming of
the donor genome. Also, the inappropriate handling of oocytes, somatic cells and embryos
during maturation with the subjection of these cells to the various necessary manipulations and
cultural techniques could result in cellular stresses leading to LOS.
Successful NT in combination with applicable genetic modifications must be conducted
using normal diploid cells before they reach senescence (Denning et al., 2001). Primary cells
utilized to establish cell culture possess the capacity to survive only a finite number of
population doublings (PDs) before cellular senescence is reached (Hayflick and Moorhead,
1961). As cells approach this limit, the rate of proliferation decreases (Cameron, 1972) and the
probability of cells to undergo cytokinetic abnormalities and chromosomal alterations increases
substantially (Giraldo et al., 2006; Oback and Wells, 2002). The current techniques employed
today to establish and maintain primary in vitro cell cultures may also be responsible for the
induction of these anomalies (Chu, 1962; Denning et al., 2001; Kasinathan et al., 2001; Oback
and Wells, 2002; Rubin, 1997). Spontaneous transformations, which will also influence the
success of NT, have been described in human and murine adipose tissue-derived
mesenchymal stem cells (MSCs) (Rubio et al., 2005) and have been reported to accumulate
proportionally to the time in culture (Oback and Wells, 2002). However, other studies indicate
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that human bone marrow and adipose tissue-derived MSCs do not mutate and maintain
chromosomal configuration through culture (Bernardo et al., 2007; Meza-Zepeda et al., 2008).
Chromosomal aberrations and a limited proliferative capacity of somatic donor cells
cultured in vitro dramatically influence the success of NT (Kasinathan et al., 2001). The
manifestation of genetic modifications in donor cells for NT requires a significant number of PDs
and, unfortunately, these deleterious effects are impossible at this time to circumvent. But the
identification of a donor cell that is genetically stable for a long period of time in vitro may be the
key to increasing the efficiency of NT.
Stem cell biology is one of the most active areas in biomedical research today.
However, there is much controversy surrounding the use of human embryonic stem cells in
research for medical applications. This controversy has spurred the focus of research to the
isolation of alternative stem cell sources. Diligent efforts in current research are focusing on the
isolation and characterization of adult stem cells. Adult stem cells have been isolated from
many different tissues including blood, fat, bone marrow, organs such as the liver and retina,
and in cord blood. Preliminary evidence suggests that these cells may be useful in clinical
applications such as tissue engineering and cord blood transplants.
MSCs are pluripotent precursors meaning that they can differentiate into any cell type
except for a totipotent cell (which can differerentiate into all cell types). MSCs can be found in
adult tissues such as adipose tissue, bone marrow (BM), and cord blood (CB). MSCs support
differentiation into adipocyte, osteoblast and other mesodermal cell types. Depending on the
culture conditions, MSCs can be cultured in vitro as pluripotent cells or differentiated cells with a
fibroblastic morphology. Gene and protein expression profiles have been defined in some
species specific MSCs showing the presence of cell surface markers such as CD34 and CD44.
At this point, knowledge of the optimal culture conditions for pluripotent and
differentiated MSCs from adipose, bone marrow and cord blood is limited. Also, culture
characteristics of these cells have not been clearly defined and studies generating gene and
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protein expression profiles are underway but still remain inconclusive. Currently, nuclear
transfer utilizing a true MSC as the donor cell is unconvincing most likely due to inefficient
isolation/purification protocols and characterization. Therefore, it is important that the true nature
and potential of these cells be defined in order to best apply them to the medical field. Also, in
lieu of the controversy associated with embryonic stem cells, an animal model must be
developed to maintain the progress of research in this area.
The inherent ability of mesenchymal stem cells such as porcine adipose tissue-derived
stem cells (pASCs) to proliferate in vitro and maintain their aptitude for pluripotency (Williams et
al., 2008) makes them attractive candidates as donor cells for more efficient reprogramming
during NT compared to somatic cells currently in use. Studies have however generated
contradicting results for the success of stem cells in NT; for example, skin-derived stem cells
increased NT efficiency (Hao et al., 2009; Zhu et al., 2004) while hematopoietic stem cells did
not (Inoue et al., 2006; Sung et al., 2006). Porcine ASCs have not been tested as donor cells
for NT at this time.
Multiple different research groups have characterized human ASCs by describing the
surface phenotype, however, there are many subtle discrepancies represented throughout the
literature. The effects of these differences on the identity of these cells remain unknown.
Various factors may play a role in producing these inconsistencies. For example, porcine ASCs
are isolated from fat depots likely different from human ASC liposuction aspirates. Also, the age
of the donor may be different and cause the results to disagree. In addition, isolation
procedures used, the specific cell seeding density, differences in culture media used, culture
duration, the cell cycle, the passage numbers analyzed, whether the cells were cryopreserved
prior to analysis and even the exposure to plastic all may cause incongruent results. Therefore,
it is important to characterize porcine ASCs on the cell surface level.
NT results in relatively low success rates and research has reported substantial
problems with the welfare of the cloned animals produced. Evidence suggests that the use of a
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less differentiated donor cell may lead to an increase in the efficiency of the NT procedure. To
this end, stem cell characteristics must be clearly defined in order to isolate, identify and
optimally culture potential donor cells. Stem cell characteristics such as self-renewal and
differentiation have not been identified in stem cells from porcine adipose tissue, an easily
attainable tissue source. At this time, the phenotypic profile of cell surface proteins and
chromosomal stability of pASCs through in vitro culture has not been described. In addition,
research has not identified epigenetic modifications in adult somatic MSCs from porcine adipose
tissue.
The objective of Project 1 was to develop a protocol for the isolation and culture of
pASCs and to determine stem cell-like characteristics. Primary cultures were established and
cell cultures were maintained. Cloning capacity was determined using a ring cloning procedure.
Primary cultures and clones were differentiated and stained for multiple differentiated
phenotypes. An average of 2,700,000 nucleated cells/ml was isolated, 26% were adherent, and
cells completed a cell cycle approximately every 3.3 d. Ring cloning identified 19 colonies.
Primary cultures and clones were determined to differentiate along osteogenic, adipogenic and
chondrogenic tissue lineages. Improved culture conditions and defined cellular characteristics
of self-renewal of these pASCs have been identified. Porcine ASCs can self-renew, can
differentiate into multiple tissue lineages and they express CD34.
The objective of Project 2 was to partially characterize the surface protein phenotype of
undifferentiated porcine ASCs and to determine the chromosomal stability through in vitro
culture. Cell surfaces were immunolabeled for stem cell surface proteins and analyzed by flow
cytometric analysis as well as by western blot analysis paired with an enhanced
chemiluminescence (ECL) kit. Metaphase spreads were prepared for each cell line and
counted to determine chromosomal stability through in vitro culture. Cells at early and late PDs
expressed CD29 and CD90. All other markers analyzed were expressed at low levels, including
CD3, CD8, CD44, CD117 (c-Kit), SSEA-4 and Sca-1. Of 714 metaphases analyzed 71.3%
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were aneuploid. Cells cultured through early PDs (PD 1-10) had a significantly lower
percentage of aneuploidy compared to cells at late PDs (PD 11-20 and PD 21-30). Porcine
ASCs do not express the stem cell surface markers analyzed at similar levels compared with
those of human ASCs reported in the literature. Also, in vitro cultured porcine ASCs used as
donor cells for NT should be chosen from early PDs due to increased levels of aneuploidy at
later PDs.
Research has indicated that the inefficiency of NT may be attributed to changes in DNA
methylation and histone acetylation as a result of the duration of somatic cell in vitro culture.
The objective of Project 3 was to analyze pASCs alongside fetal porcine fibroblasts (FPF) for
gene expression profiles of chromatin remodeling proteins and global methylation and
acetylation patterns and to determine the presence of bivalent domains harboring both histone
H3 lysine 4 and 27 tri-methylation within the promoter regions of developmentally important
transcription factors. Cells were immunolabeled with anti-5-methylcytidine and anti-acetyl
histone H3 and analyzed by flow cytometric analysis. Messenger RNA (mRNA) was isolated
and reverse transcribed into complementary DNA (cDNA). Quantitative PCR (qPCR) was
performed and a mean fold change in transcript expression was determined. Chromatin
immunoprecipitation assay coupled with a qPCR was used to determine the presence of the
bivalent domains. pASCs demonstrated a consistently lower level of DNA methylation and
histone acetylation through passages 2 through 7; whereas, the patterns for FPFs varied. The
expression levels of chromatin remodeling transcripts remained lower in pASCs throughout
culture when compared to FPFs. pASCs possess the bivalent chromatin structure within the
promoter region of the developmentally important transcription factor OCT-4. Further
characterization of porcine ASCs in this manner could assist the isolation and purification of a
population of MSCs from the easily obtainable tissue of adipose that can later be tested as
donor cells in nuclear transfer.
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Cutting edge methods for producing transgenic animals still need much improvement
considering the inefficiency and expenses involved. Researchers in industry are engineering
bacteria or mammalian cells into bioreactors for producing recombinant proteins for therapeutic
treatments. However, these tiny bodies are incapable of producing the necessary mass
quantity to adequately service the growing demand. The current shortfall hinders such
therapeutic products from entering the marketplace thereby preventing patient access to new
therapies, which in turn denies revenue to pharmaceutical companies who have invested large
sums of money in product development.
By employing cells such as somatic stem cells or cells demonstrating stem-like
characteristics as donor cells for nuclear transfer, resultant anomalies such as those which
classify LOS may be averted and increase the success rates of nuclear transfer. An increase in
the efficiency of transgenic animal production will provide a substitute factory for the
manufacture of these recombinant proteins and offer a more cost effective mechanism for the
production of large quantities (i.e., kilograms). An increased efficiency will also shorten the time
required to produce an adequate number of live transgenic offspring for pharmaceutical and
other biomedical purposes and therefore decrease the ultimate cost of production. In turn, this
will eliminate economic barriers currently blocking the application of this technology from
commercial large-scale production of transgenic animals and therefore make transgenic animals
a more appealing method of producing recombinant proteins.
Controversy associated with the use of human tissues necessitates the development of
an animal model to continue research in this important area. Many treatments have already
resulted from the use of tissues generated through advancements made in the porcine animal
model. Therefore, the improvement of culture conditions and the definition of cellular
characteristics for the efficient isolation and purification of a population of MSCs from porcine
tissues to be used as donor cells in nuclear transfer will create an important animal model for
additional future biomedical applications.
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CHAPTER II
LITERATURE REVIEW
Clinical Applications of Stem Cell Biology
The potential impact of the field of regenerative medicine has a multitude of applications
through stem cell biology. The expansion of our basic knowledge of stem cell biology will greatly
impact scientific areas including development, cancer, and aging as well as provide a
foundation for the development of tissue engineering (Merok and Sherley, 2001). An array of
scientific disciplines have joined efforts to develop the techniques involved in tissue engineering
for repairing, replacing, or regenerating diseased tissues and organs. With the advancement of
this biotechnology, for example, scaffold biomaterials can be combined with a variety of stem
cells to treat disease through cell-based therapies. Other cell therapeutic applications include
bone marrow transplants, cartilage, tendon, ligament, and bone repair, treatment of vascular
disease and even the production of transgenic animals (Merok and Sherley, 2001).
Several applications involve the technique of cell transplantation. Embryonic stem cells
have the capability to form biologically functional cell populations suitable for integration,
response and function within a diseased tissue. Embryonic stem cells produce these cell
populations in response to signaling pathways induced by factors such as cytokines,
transcription factors and cell-to-cell interactions. Multiple cell populations derived from
embryonic stem cells, including cardiomyocytes (Klug et al., 1996), insulin-secreting cells (Soria
et al., 2000) and neuronal precursor cells (Brustle et al., 1999; McDonald et al., 1999) have
been successfully integrated within the host tissue and displayed the appropriate cell functions.
For example, upon transplantation into the spinal cords of myelin-deficient rats, glial precursor
cells derived from embryonic stem cells successfully differentiated into astrocytes and
oligodendrocytes capable of forming myelin at the site of injection and in migration several
millimeters away from the injection site (Brustle et al., 1999; Liu et al., 2000).
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Candidate cells for such promising applications must meet several requirements to be
eligible for classification as a stem cell population. Cells must have the capacity for selfrenewal, must have long-term viability and must have the ability to give rise to differentiated cell
types to be considered “stem cells.” The isolation and culture of large numbers of cells that will
uniformly differentiate to a functional state, such as those embryonic stem cell-derived glial
precursors, is necessary to gain eligibility for application to cell therapies (Tsai et al., 2002).
Stem Cell Definition
In 1855, Franz von Leydig postulated that life did not begin in a spontaneous fashion but
rather from preexisting life. In agreement with his hypothesis, Rudolf Virchow developed a
theory called omnis cellula e cellula meaning that all cells within an organism arise from
preexisting cells (Oberling and Woglom, 1944). With these concepts, scientists began
describing stem cells with the understanding that all cells are derived from the fertilized ova. For
example, Edmund Beecher Wilson began describing mitotically quiescent primordial germ cells
in 1896 (Wilson, 1896). Collectively, these pioneering minds initiated the standing concept that
a stem cell is the functional unit of life that gives rise to progeny cells that can differentiate into
the cells of the various tissues that make up an organism.
Stem cells are genetically identical to the stem cell from which it was derived, that is to
say stem cells are clonogenic in nature. Theoretically, a stem cell can undergo an infinite
number of repeated cell divisions for many generations without differentiating into a specialized
cell of a certain tissue or function. During early embryonic development, cell division gives rise
to two daughter cells each with a full chromosome complement and the capability of forming all
differentiated cell types. Division in this manner is referred to as symmetric division (Merok and
Sherley, 2001). Adult stem cells, or those stem cells derived from adult tissues, demonstrate
asymmetric division which yields two daughter cells including one cell that remains a progenitor
cell and one cell that begins the process of terminal determination or differentiation (Merok and
Sherley, 2001).
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Again, stem cell requirements include the capacity for self-renewal, long-term viability
and the ability to give rise to differentiated cell types. Differentiation of stem cells into
specialized precursor cell types will commence as a result of inherent genetic characteristics
and in response to multiple environmental cues. Various cytokines, transcription factors, growth
factors and cell-to-cell interactions dictate the fate of cell commitment. In 1974, Friedenstein
determined that exposing cells to increasing amounts of serum fibroblast growth factor-2 caused
the cells to initiate cell cycle activity (Friedenstein et al., 1974). In addition to growth factors, a
lower seeding density can increase the expansion rate of cells in vitro as well as increase
differentiation potential (Sekiya et al., 2002).
Stem Cell Potential
Stem cells with the capability of generating all tissue types of an organism, including
cells of the placenta, are classified as totipotent cells. Totipotent cells include the combined
sperm and egg, or germ cells. Totipotent cells give rise to pluripotent and multipotent stem
cells. Pluripotent cells can differentiate into cells that make up tissues of the three germ layers:
endoderm, mesoderm and ectoderm. On the other hand, multipotent cells can only differentiate
into the cell types that make up the germ layer from which they came. Friedenstein
demonstrated that bone marrow cells can differentiate into osteocytes of bone tissue
(Friedenstein et al., 1966). However, recent reports suggest there are exceptions to these
general classifications. For example, mesenchymal stem cells (MSCs) from the mesoderm
have been shown to differentiate into nerve cells that are derived from the ectoderm (Pittenger
et al., 1999).
Embryonic Stem Cells
Fertilization of an ovum initiates a procession of cell divisions, also known as cleavage,
which drive an embryo through the various developmental stages including the zygotic stage,
the morula stage and the blastula stage. The union of the haploid sperm and egg forms the
diploid zygote before the onset of cell cleavage. The zygotic cell undergoes multiple cell
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divisions and a process known as compaction takes place in which cells begin to stick together
through cell-surface adhesion glycoprotein interactions. The inner most cells, or blastomeres,
become the inner cell mass (ICM) and the outer cells form the trophoblast. At this stage, the
developing embryo is referred to as a blastocyst. Blastocysts form at approximately 5 days post
fertilization in the human and 7 days in the cow. Preimplantation blastocysts consist of an ICM
and a fluid-filled blastoceole, which are encapsulated in a layer of cells called the
trophectoderm. Cells of the ICM give rise to the three germ layers while the cells of the
trophectoderm form the placental tissues.
In 1981, Evans and Kaufman and Martin and coworkers independently established in
vitro culture of embryonic stem cells derived from the ICM of the preimplantation mouse embryo
(Evans and Kaufman, 1981; Martin, 1981). Both groups utilized co-culture with fibroblast feeder
layer cells that maintain embryonic stem cell pluripotency and prevent differentiation. The cells
in culture demonstrate chromosomal stability (Pera et al., 2000) and differentiation potential as
embryoid bodies, which recapitulate embryonic development but do not form extraembryonic
tissues (Evans and Kaufman, 1981). Also, reports characterizing embryonic stem cells showed
that they can integrate into the construction of all tissue types after injection into an early stage
mouse embryo (Robertson et al., 1986; Thomas and Capecchi, 1987) and that they express a
multitude of pluripotent stem cell surface markers (Rogers et al., 1991; Rosner et al., 1990).
Somatic Stem Cells
Human patient pathologies for progressive osseous heteroplasia (POH) and fibrosis
ossificans progressive (FOP) exhibit the formation of ectopic bone within subcutaneous adipose
tissues, muscles, tendons and ligaments (Kaplan et al., 1994a; Kaplan et al., 1994b).
Therefore, these afflicted tissues contain a mixture of cells, typically of mesenchymal origin,
including osteoblasts (Kaplan et al., 1994a). POH can be acquired in response to burns,
infections, trauma, post-surgical complications, neoplasia and neurologic disease (Puzas et al.,
1989). POH is also a rare autosomal dominant inheritable disease in which a mutation in the
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GNAS1 gene prevents the coupling of hormone receptors to adenylate cyclase (Shore et al.,
2000). The pathologic observations associated with POH indicate the presence of progenitor
cells within adult tissues.
Pathological observations such as those in POH have spurred the exploration of other
sources of progenitor cells or adult stem cells. Sources of adult stem cells, also known as
somatic stem cells, have been found in a multitude of tissues including bone marrow
(Friedenstein et al., 1976), adipose (Rodbell, 1964; Zuk et al., 2001), cord blood (Broxmeyer et
al., 1992) and skin (Toma et al., 2001). Somatic stem cells are not totipotent, but may be
considered pluripotent and definitely multipotent in that they can differentiate into tissue lineages
of the germ layer from which they came. At this time, hematopoietic stem cells (HSCs) are the
best characterized of somatic stem cells and multiple studies have been performed to illustrate
their plasticity or ability to give rise to progeny of different cell types. Jahagirdar and Verfaillie
demonstrated that not only could HSCs give rise to fat, bone, muscle and cartilage but also to
gut, liver, lung and endothelial cells (Jahagirdar and Verfaillie, 2005). Also in 2005, Mezey
demonstrated that HSCs could differentiate into brain cells (Mezey, 2005). These reports along
with many others support the theory that somatic stem cells possess a more pluripotent capacity
rather than the stricter multipotent characteristic as once thought.
Embryonic Stem Cells vs. Somatic Stem Cells
Under optimal in vitro culture conditions, somatic stem cells can demonstrate expansion
rates of up to approximately 50 population doublings (PDs) (Friedenstein et al., 1974) similar to
all other eukaryotic cell lines cultured in vitro as defined by the Hayflick limit (Hayflick and
Moorhead, 1961). However, embryonic stem cell populations are believed to possess a longer
lifespan in vitro. Human embryonic stem cells have maintained an undifferentiated state and a
normal karyotype in vitro for up to 250 PDs (Amit et al., 2000). These observations suggest that
embryonic stem cells may in fact be more useful in their applications than somatic stem cells.
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The longer lifespan of embryonic stem cells compared with somatic stem cells may be
attributed to the length of telomeric DNA and telomerase activity. In 1985, Carol Greider and
Elizabeth Blackburn discovered the enzyme telomerase in the ciliate Tetrahymena (Greider and
Blackburn, 1985). Telomerase is responsible for adding TTAGGG specific sequence repeats to
the 3’ end of DNA following each replication cycle (Greider and Blackburn, 1985). The
condensed repetitive DNA sequence, also known as the telomere, protects the chromosome
ends from homologous recombination and non-homologous end joining. The present
understanding is that a decline in telomerase activity is associated with aging cells and that
telomere length shortens as a result of incomplete replication (Counter et al., 1992; Harley et al.,
1992). As telomere length shortens, the cell progresses closer to its replicative limit,
accommodating Leonard Hayflick’s postulation of limited somatic cell division (Hayflick and
Moorhead, 1961), therefore advancing into replicative cellular senescence (Counter et al., 1992;
Harley et al., 1992). Embryonic stem cells and malignant cells have been shown to have
elevated levels of telomerase activity (Kim et al., 1994) lending to the virtual immortality of
embryonic stem cells in vitro and the evasion of cancer cells from programmed destruction.
However, somatic stem cells and somatic cells in general possess low levels of telomerase
activity if any at all (Rubin, 2002; Wright and Shay, 2002).
Although embryonic stem cells may prove to be more versatile in therapeutic
applications, much controversy surrounds the use of stem cell sources derived from human
embryos and fetuses for biomedical treatments. The current media has illuminated stem cell
research in a negative light by portraying all stem cells as those only from embryonic origin at
the price of human embryo destruction. Also, the inability to completely purify embryonic stem
cell populations for use in clinical applications has maintained the potential for cancerous tumor
formation. The public belief has influenced the political circuit and as a result, the U. S. National
Institutes of Health lists only 21 embryonic stem cell lines available for distribution for research
nationwide in 2009.
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Therefore, the controversy has spurred research of alternative stem cell sources. The
use of adult or somatic stem cells, found in adult tissues, escapes the controversy and also
eludes immunological rejection and disease contraction (Merok and Sherley, 2001). Diligent
efforts of current research are now focusing on the isolation and characterization of adult or
somatic stem cells. Somatic stem cells can be found among differentiated tissues, however
current research is focusing on more easily attainable sources with less patient discomfort.
Ongoing research is also concentrating on the isolation and culture of large numbers of cells
that will uniformly differentiate into a functional state to then become eligible for applications in
cell therapies (Tsai et al., 2002).
Mesenchymal Stem Cells
To this date, many scientists are working vigorously to ascertain the true stem cell
renewal capabilities of those cells referred to as mesenchymal stem cells or stromal cells or
MSCs. It remains to be determined whether they can demonstrate the ability to divide
producing a daughter cell that remains a precursor cell as well as produce a daughter cell that
will differentiate along a specific mesenchymal cell lineage. For the purpose of terminology,
MSCs are a type of somatic stem cell found in adult tissues such as adipose tissue, bone
marrow and cord blood that are believed to be, for the most part, pluripotent precursors. In
1970, Friedenstein and colleagues first identified MSCs isolated from bone marrow as fibroblast
precursors and referred to them as colony-forming unit-fibroblastic (CFU-f), which describes
fibroblastic colony growth (Friedenstein et al., 1970). Traditionally, MSCs have been isolated
from various tissues based on their ability to adhere to plastic and their morphology similar to
that of fibroblasts (Kassem et al., 1993; Luria et al., 1971; Rickard et al., 1996). Depending on
the culture conditions, MSCs can be cultured in vitro as pluripotent cells or as differentiated
cells. MSCs support differentiation into adipocyte, osteoblast and other mesodermal cell types
(Gimble et al., 1990; Gimble et al., 1996; Nuttall and Gimble, 2000; Owen, 1988).
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As previously stated, HSCs have been more extensively characterized than any other
somatic stem cell type. However, the niche or environment in which the HSC develops and
functions is still very poorly understood. Recent studies have revealed that cells derived from
MSCs, such as osteoblasts and fibroblasts, interact directly with functioning HSCs. MSCs have
also been shown to play major roles in the regulation of hematopoiesis (Mitsiadis et al., 2007).
Molecules produced by MSCs have a potent paracrine effect within the niche that ultimately
regulates the proliferation rate of HSCs and their function (Orkin and Zon, 2008; Wilson and
Trumpp, 2006).
A multitude of reports describe the cell surface phenotypic profile of MSCs. However,
through the extensive exploration, conflicts in results have prevented the establishment of
inimitable, identifiable cell markers for MSCs. Haynesworth and coworkers demonstrated that
SH2, SH3 and SH4 can be used to distinguish MSCs from contaminating HSC populations
(Haynesworth et al., 1992). In addition, STRO-1 antibodies have been employed to select for
MSCs in bone marrow by magnetic activated cell sorting (Dennis et al., 2002; Gronthos et al.,
1994; Tamayo et al., 1994). STRO-1 selected cells have been shown to be chondrogenic,
adipogenic, and support hematopoiesis (Dennis et al., 2002) as well as osteogenic (Gronthos et
al., 1994). Gene and protein expression profiles in some species specific MSCs show the
presence of cell surface markers, such as CD34, CD44 (Gronthos et al., 2001) and SSEA-4
(Gang et al., 2007). Yet, according to the Mesenchymal and Tissue Stem Cell Committee of the
International Society for Cellular Therapy, a cell can only be classified a MSC if proved to be
negative for CD11b, CD14, CD19, CD34, CD45, CD79a and HLA-DR and positive for CD73,
CD90 and CD105 (Dominici et al., 2006).
MSCs in culture exhibit a high degree of plasticity as suggested above. The process of
differentiation was traditionally thought to be an irreversible pathway to a committed cell lineage.
However, differentiated MSCs possess the ability to dedifferentiate and transdifferentiate into
other cells of mesenchymal origin such as adipocytes, chondrocytes and osteoblasts (Song and
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Tuan, 2004). Song and Tuan even rule out the potential for progenitor cell contamination within
the originating stem cell pool and cell-to-cell fusion of progenitor cells and tissue-specific cells
(Song and Tuan, 2004). In addition, human articular chondrocytes have been shown to
differentiate into osteogenic and adipogenic pathways and cultured adipocytes into the
chondrogenic or osteogenic pathways (Sato et al., 2005; Tallheden et al., 2003). In spite of
these findings, research continues to explore the specific dedifferentiation and
transdifferentiation capabilities of MSCs.
MSCs have been applied in cell-based therapies for the treatment of such conditions as
bone and cartilage defects, injuries to spinal cord and nervous system, lung diseases and
cardiac disorders. As mentioned above, MSCs exert paracrine effects by the secretion of
bioactive molecules making them appealing for use in cell-based therapies. MSCs have been
injected following bone marrow transplants in order to speed up patient recovery (Le Blanc et
al., 2004). Also, tissue engineering using the combination of MSCs and scaffolds of a specified
biomaterial and shape can be used in grafts (Kojima et al., 2004) with minimal host rejection (Le
Blanc et al., 2004).
MSC Cell Surface Phenotype
In the field of stem cell biology it is important to be able to recognize, identify and
distinguish one specific stem cell population from another. Multiple techniques exist for the
isolation of plastic-adherent multipotent cells from adult tissue sources, however, all render a
heterogeneous population of cells with discrepant proliferation characteristics and differentiation
potentials. Identifiable stem cell populations are necessary in order for researchers to be able
to describe localization, function and therefore mechanism of tissue repair. The quest for a cellsurface antigen profile for MSCs of all types is presently ongoing. Consequently, the
understanding as to what a MSC actually is requires better definition.
The current method of physical phenotyping of MSCs populations relies on a
combination of cell surface markers briefly described above. There is a plethora of reported
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positive cell surface markers for MSC identification in which different laboratories employ
different combinations of markers. Consequently, it is important to keep in mind that the lack of
unique, standardized molecules leaves considerable room for generating discrepant results
from varying research groups. As mentioned above, SH2, SH3, SH4 and STRO-1 are among
the most well known MSC surface markers. SH3 and SH4 are monoclonal antibodies that were
raised against CD73, a 5’ ecto nucleosidase, and were developed with specificity for MSCs
(Haynesworth et al., 1992). The specificity for CD73 of MSCs prevents the selection of HSCs,
osteoblasts and other contaminating cell populations. There are, however, discrepancies to
consider when relying on STRO-1 alone in general MSC identification. STRO-1 expression is
unfortunately not limited to MSCs, and unlike CD73, STRO-1 expression is lost through
expansion in culture (Gronthos et al., 2003). The decline in STRO-1 expression restricts the
use of STRO-1 as an identifiable marker to primary and early MSC cultures only (Gronthos et
al., 2003). It has been proposed that the use of STRO-1 is better exploited in combination with
other MSC identifying cell surface markers (Gronthos et al., 2003).
Vascular cell adhesion molecule-1 or CD106 has been identified as a cell surface
marker that can be used in conjunction with other markers for positive MSC population
identification. Considering the caveats of utilizing STRO-1 alone, Gronthos and coworkers
demonstrated that CD106 amplified the selection of multipotential, colony forming cells that
coexpress STRO-1 with high telomerase activities (Gronthos et al., 2003). Other positive MSC
cell surface markers include CD10 (metalloproteinase; CALLA), CD13 (metalloproteinase;
Aminopeptidase N), CD14, CD29 (integrin "1; fibronectin receptor), CD44 (adhsion receptor
molecule; hyaluronate), CD49a, CD63, (HOP-26), CD71, CD73, CD90 (Thy-1), CD105
(adhesion receptor molecule; Endoglin), CD120a, CD124, CD166 (SB-10), CD271 (NGFR),
CD309 (Flk-1) and stem cell antigen-1 (Sca-1) (Gronthos et al., 1994; Koc et al., 2000; Mitchell
et al., 2006; Pittenger et al., 1999; Stewart et al., 2003). However, it is important to note that
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other researchers have reported conflicting results concerning MSC expression of CD10, CD90,
CD309, Sca-1 and others.
Selection of a homogeneous population of MSCs might be accomplished with the use of
both positive and negative cell surface markers. Markers that have been reported not to be
present upon the MSC surface include: CD11b, CD14, CD19, CD31, CD34, CD45, CD79a,
CD117 and HLA-DR (Colter et al., 2001; da Silva Meirelles et al., 2006; Pittenger et al., 1999).
MSC Self-renewal and Maintenance
A recent shift in MSC research has focused on unraveling the intricate machinery
involved in stem cell self-renewal and maintenance. The mechanisms of self-renewal function
to preserve the undifferentiated state of the stem cell and are dictated by extrinsic signals and
several intrinsic factors including epigenetic modifications and small RNA regulators. Leukemia
inhibitory factor (LIF), multiple growth factors and other soluble factors such as Wnt, Notch and
Sonic hedgehog (Shh) have all been implicated in the mediation of stem cell self-renewal and
maintenance. The detailed mechanism of the LIF pathway is unknown, however it has been
shown to maintain the undifferentiated state of MSCs (Jiang et al., 2002) as well as
activate/repress bone cell activities (Heymann and Rousselle, 2000).
Growth factors such as epidermal growth factor (EGF), fibroblast growth factor-2 (FGF2) and transforming growth factor-alpha (TGF-#) regulate stem cell replication via the
extracellular environment (Reynolds et al., 1992; Reynolds and Weiss, 1992; Tsutsumi et al.,
2001; Zaragosi et al., 2006). Apparently, EGF, FGF-2 and TGF-# play a role in the control of
receptor tyrosine kinase signaling essentially preserving the stem state of MSCs and extending
their viability in culture (Tsutsumi et al., 2001; Zaragosi et al., 2006).
Wnts have been shown to be major players in the proliferation of adult human MSCs by
initiating the cascade involving "-catenin and cyclin D1 (Boland et al., 2004; Willert and Nusse,
1998). Wnt3a specifically increased MSC proliferation while suppressing osteogenic
differentiation (Boland et al., 2004). Notch functions as a paracrine factor released from a
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neighboring cell within the MSC niche, which transduces signals into the nucleus of the cell
affecting gene expression for maintaining the undifferentiated state (Jarriault et al., 1995; Yoon
and Gaiano, 2005). Lastly, Shh is also considered an important component of enhancing
proliferation capacity of MSCs. Hepatic stellate cells increased Shh expression after coculture
with MSCs, in which stellate cells then served in a paracrine fashion to elevate the proliferation
and differentiation of the MSCs delivered through treatment of liver fibrosis (Lin et al., 2008).
Stem cell self-renewal and the maintenance of the undifferentiated state are also
controlled by epigenetic modifications. These modifications include histone acetylation,
methylation, phosphorylation, ubiquitination, sumoylation, citrullination and ADP-ribosylation
(Strahl and Allis, 2000). The expression levels of the enzymes responsible for producing these
modifications ordain epigenetic control. For example, DNA methyltransferases (Dnmt) add
covalent methyl groups (-CH3) to cytosine bases located within the promoter region of a gene
(Geiman and Robertson, 2002). The resultant methyl group is associated with transcriptional
silencing as a result of the inability of transcription factors to bind to methylated DNA sequences
(Hiendleder et al., 2004a). Also, histone acetylation occurs through the histone acetylases or
HATs and modifications are removed via histone deacetylases or HDACs. The removal of
histone acetylated groups primarily from histone H3 and H4 causes significant changes in the
shape or configuration of the chromatin that then prevents the access of transcription factors to
bind DNA sequences (Cezar, 2003). Without access to the DNA, transcription cannot
commence, therefore the cell remains in a stem state all on account of the specific interactions
between the DNA and chromatin remodeling proteins.
The epigenetic landscape created by these modifying enzymes has been under close
investigation recently. Methylation modifications have been described on targeted genes just
downstream to a variety of developmentally important transcription factors such as Oct4,
Nanog, Sox2, c-Myc, and Klf4. These particular transcription factors have been implicated in
human development and are believed to be necessary for the maintenance of pluripotential and
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the regulation of self-renewal pathways (Boyer et al., 2005). Stem cell self-renewal under
transcriptional control is associated with the degree of lysine methylation including mono-, di- or
tri-methylated histones. Dnmts and demethylases facilitate chromatin modifications to form a
described “bivalent” conformation that consist of regions of histone 3 (H3) lysine 27 methylation
harboring smaller regions of H3 lysine 4 methylation (Bernstein et al., 2006). Studies show that
methylation of lysine 4 positively mediates transcription by recruiting histone acetylases and
other chromatin remodeling enzymes (Santos-Rosa et al., 2003) while lysine 27 negatively
mediates transcription by preserving a closed chromatin conformation (Francis et al., 2004;
Ringrose et al., 2004). The methylation pattern functions to repress transcription while holding
the chromatin in a potentially activate state. Other transcriptionally repressive demarcations
include H3 trimethyl lysine 9, H3 monomethyl lysine 20 and H3 lysine 27 methylation, and all
can be found in neuronal stem cells (Shi et al., 2008; Wernig et al., 2007).
Small non-coding RNA regulators also control cell proliferation and other cellular
processes involved in development (Wienholds et al., 2005). Micro-RNAs (miRNA) are singlestranded RNA fragments transcribed from DNA but not translated into proteins. Primary miRNA
transcripts (pri-miRNA) are processed within the nucleus into short stem-loop or hairpin-like
structures called pre-miRNAs. These pre-miRNAs translocate into the cytoplasm where they
interact with the endonuclease Dicer that cleaves pre-miRNA into two complementary RNA
molecules. One of the complements created integrates into a RNA-induced silencing complex
or RISC and guides the complex to complementary portions of messenger RNA. The
interaction represses translation thereby preventing differentiation either by a physical block or
the cleavage of target mRNAs.
MSC Differentiation
Following the successful isolation and identification of a cell population thought to be
MSCs, further characterization must be performed to determine the ability of the population to
differentiate. The elucidation of specific signaling networks involved in the differentiation of
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MCSs remains unclear. However, several intrinsic as well as extrinsic factors from the cell’s
environment, as mentioned above, influence cell and tissue differentiation.
MSCs exist in their respective niche within varying tissues as quiescent cells arrested in
the G0/G1 cell cycle stage until an extracellular cue from the cell’s environment induces
proliferation and differentiation of that cell (Baksh et al., 2004). MSCs are adult or somatic stem
cells and, also as mentioned above, divide in an asymmetric manner where the tissue
progenitor cells give rise to two daughter cells, one that remains a progenitor cell and one
precursor cell that begins the process of terminal differentiation. The resultant progenitor cell
goes on to continue the asymmetric division pattern to replenish the MSC population within the
tissue from which it came for future use in tissue repair or regeneration in the case of injury or
disease. The precursor cell formed can further divide to produce multipotent cells that can
differentiate along specific cell lineages such as chondrocytes, osteoblasts, adipocytes and
myocytes. Cytokines, extracellular matrix proteins and other soluble factors are responsible for
dictating this division process and the timing of their function is likely very important (Baksh et
al., 2004).
In order to facilitate the development of optimal culture conditions of MSCs for
appropriate clinical applications, Baksh and coworkers investigated the presence of a myriad of
transcripts before and after the induction of lineage differentiation including osteogenesis,
chondrogenesis and adipogenesis. They propose a model for the regulation of MSC
differentiation suggesting that due to the presence of many common genes, osteogenesis,
chondrogenesis and adipogenesis are likely governed by a single master control mechanism
(Baksh et al., 2004).
MSC Differentiation: Chondrogenesis
Molecular investigations have identified multiple instructive signaling molecules that
induce the expression of specific chondrogenic genes. The discovery of these molecules has
led to their incorporation into culture medium allowing chondrogenic differentiation in vitro.
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Kisiday et al. compared bone marrow and adipose tissue-derived MSCs for their ability to
express benchmark chondrogenic genes after culture in media with and without transforming
growth factor-"1 (TGF-"1) and found that TGF-"1 media did in fact upregulate the expression of
collagen type II (Kisiday JD, 2007). MSC-derived chondrocytes then positively express
chondrogenic-associated markers including transcription factor Sox-9 (Sry-type high mobility
group box containing gene 9) and extracellular matrix genes such as collagen II, collagen IX,
aggrecan, decorin, glycan and cartilage oligomeric matrix protein (Baksh et al., 2004; Tuan et
al., 2003). Additional research indicates that chondrogenesis of MSCs can be induced by the
presence and combination of other molecules including TGF-"3, bone morphogenetic protein-2
(BMP-2), BMP-4, BMP-6 (Boskey et al., 2002; Gooch et al., 2002), BMP-12 (Gooch et al.,
2002), BMP-13 (Gooch et al., 2002; Nochi et al., 2004), growth and differentiation factor-5
(GDF-5) (Tuan et al., 2003), ascorbic acid and dexamethasone (Awad et al., 2003; Erickson et
al., 2002; Guilak et al., 2004; Zuk et al., 2001).
Ongoing investigations are exploring the roles of TGF-"s and BMPs in MSC
differentiation mechanism because they signal through mitogen-activated protein kinases
(MAPKs) and R-Smad proteins. The MAPK cascades phosphorylate HATs that then bind RSmad proteins (Abecassis et al., 2004). Again, HATs modulate the addition of an acetyl group
to histones thereby opening up chromatin conformation increasing the accessibility of
transcription factors to bind DNA sequences and inducing chrondrogenesis in MSCs.
MSC Differentiation: Osteogenesis
Recent data suggests that there is most likely a close relationship between the
processes of adipogenesis, osteogenesis and chondrogenesis in MSCs supporting the
presence of multiple common genes observed by Baksh et al. (Baksh et al., 2004). However, it
is proposed that adipogenesis and osteogenesis have more regulatory control genes and
precursors in common than those involved in the chondrogenesis pathway (Baksh et al., 2004;
Muraglia et al., 2000). Regulating transcription factors have a completely opposite effect on the
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control of osteogenesis (Beresford et al., 1992; Nuttall and Gimble, 2004). The inverse
communication between these committed cell lineages instigates the potential for exploitation of
the phenomenon in therapeutic applications.
Peroxisome proliferator-activated receptor ! (PPAR!) is an important regulator of both
adipogenesis and osteogenesis. While PPAR! promotes adipogenesis of MSCs it sequesters
osteogenesis (Nuttall and Gimble, 2004). Runx2 is a major regulating gene for the onset of
osteogenesis. Runx2 interferes with cyclin-dependant kinase inhibitors p21 and p27 lifting cell
cycle arrest and allowing the cell to progress into the S phase (Lian et al., 2006). PPAR! blocks
DNA binding of transcription factor Runx2, therefore preserving the quiescent state of the cell
and blocking the development of the osteogenic phenotype (Lian et al., 2006). Also, histone
deacetylases 4 and 5 remove acetyl groups from Runx2 allowing for its degradation by Smurf1,
Smurf2 and E3 ubiquitin ligases (Jeon et al., 2006). Tumor necrosis factor-# (TNF-#), a
cytokine involved in systemic inflammation, also induces Runx2 degradation by stimulating
increased expression of Smurf1 and Smurf2 (Kaneki et al., 2006). On the other hand, BMP-2
modulates the action of Runx2 by inducing p300 recruitment of histone acetylases, which in turn
enhance osteogenic differentiation (Jeon et al., 2006).
MSC Differentiation: Adipogenesis
PPAR-! can be inhibited by many factors including those described above as well as by
a variety of cytokines and growth factors. Regardless, PPAR-! is the central regulatory unit for
the promotion of MSC adipogenesis. PPAR-! complexes with the retinoid X receptor (RXR) that
together causes the activation of CCAAT/enhancer binding proteins (C/EBP) (Rosen and
Spiegelman, 2000). C/EBPs play a major role in the maturation of adipose tissue and without
their expression adipogenesis is severely retarded as demonstrated in knockout mice (Tanaka
et al., 1997).
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Common components of adipogenic-inducing culture media include:
methylisobutylxanthine, dexamethasone, insulin and fetal bovine serum, which by some
unknown mechanism induce the action of C/EBP family members. Specifically, C/EBP#
activates multiple genes unique to mature differentiated adipocytes including stearoyl CoA
desaturase (SCD1), insulin-responsive glucose transporter-4 (GLUT-4), phosphoenolpyruvate
carboxykinase (PEPCK) and UCP genes that have functional binding sites within their promoter
regions (Christy et al., 1989; Park et al., 1990; Yubero et al., 1994).
The toggle between stretch and non-stretch induced pathways dictates tensioninduced/inhibited protein (TIP) activation. TIPs are chromatin remodeling proteins with inherent
HAT activity. The mechanical force of tension or “stretch” inflicted upon the MSCs will affect the
lineage of differentiation that the cell will pursue (Jakkaraju et al., 2005). Under non-stretch
conditions TIP-1 is activated and promotes the onset of adipogenesis (Jakkaraju et al., 2005).
On the other hand, static stretch will activate the TIP-3 pathway leading to the induction of
myogenesis (Jakkaraju et al., 2005). On some occasions non-stretch conditions will induce TIP1 activation through RhoA mediation (McBeath et al., 2004). Through this unique mechanism,
cell shape alters the cytoskeletal structure, which in turn fires signals altering transcription and
therefore differentiation potential of the MSC.
MSC Differentiation: Myogenesis and Tenogenesis
The induction of myogenesis for muscle generation and tenogenesis for tendon
generation has also been studied. Bone marrow MSCs have been shown to differentiate into
muscle tissue for treatment following muscle degeneration when transfected with an active form
of the single-pass transmembrane receptor Notch-1(Dezawa et al., 2005). Further research has
identified the ligand for the Notch-1 transmembrane receptor as Jagged 1, also known as
CD339 (Li et al., 2006). Li and coworkers cocultured MSCs with cardiomyocytes from neonatal
rat ventricles producing an inductive environment for the differentiation of MSCs into
cardiomyocytes (Li et al., 2006). Soluble Jagged 1 was added to the culture media, which
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enhanced myogenesis of the MSCs through the Notch-1 pathway (Li et al., 2006). A
mechanism involving R-Smad8 and BMP-2 has been shown to cause differentiation of MSCs
into tenocytes (Hoffmann et al., 2006). An active form of Smad8 was cotransfected with BMP-2
into MSCs, which produced morphological changes and gene expression profiles similar to
tenocytes (Hoffmann et al., 2006). In vitro culture of induced myogenic and tenogenic cell
populations will be very useful in the treatment of these tissues when damaged or diseased.
Adipose Tissue
Adipose tissue can be found throughout the entire human body. There are two different
types of adipose tissue that are physiologically unique from each other and have completely
different functions: white adipose tissue (WAT) and brown adipose tissue (BAT). The cells
comprising WAT often contain one large lipid filled vacuole that takes up the majority of the cell
itself leaving just enough room for the nucleus. WAT can be found subcutaneously and in
visceral depots. It functions primarily as an energy reservoir but also plays roles in lipid
metabolism, insulation, mechanical cushioning, structural support, and regulating hematopoeisis
and osteogenesis. BAT cells contain many lipid filled vacuoles and multiple mitochondria that
give the cells their brown color (Hull and Segall, 1966). BAT is located in the interscapular
region and around major organs such as the heart and lungs. Energy is converted into heat
within these cells to maintain body heat in early youth and hibernating animals.
Over the past several decades, the prevalence of overweight and obese people has
drastically increased. The worldwide epidemic has drawn the attention of many research
arenas. A Pubmed search for “obesity” over the past 60 years brings up articles that have
increased progressively with each decade. With the infiltration of technology in our everyday
lives and an abundant food supply, obesity in the United States has reached astronomical
proportions and has become the number one concern in childhood health.
Obesity results when a severe imbalance between energy intake and expenditure
occurs. Adipose tissue by nature serves as a reservoir for energy to be used during periods of
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starvation. As long as energy intake exceeds expenditure, adipocytes will accommodate the
storage of energy by increasing in size and number until the balance is tipped and energy
expenditure begins to deplete the supply. However, in 1999, Roger Cone proposed a model for
the regulation and maintenance of a certain volume of adipose tissue within an individual. A
drop in the overall volume of adipose tissue due to dieting, strenuous exercise or liposuction
triggers a homeostasis modulator to return the total adipose tissue volume to its original level.
Also, classic experiments performed in rats by Faust et al. demonstrate that the removal of
inguinal fat pads stimulated regeneration within 7 months of surgery (Faust et al., 1977).
Therefore, the processes involved in adipogenesis leading to obesity suggests the presence of
a population of stem cells located in specific fat depots.
Adipose-derived Stem Cells
MSCs have been isolated from a myriad of mammalian tissues including the placenta
(Yen et al., 2005), nervous tissue (Baksh et al., 2004), brain, thymus, lung, kidney, liver, spleen
(da Silva Meirelles et al., 2006), brain (Jiang et al., 2002) and pancreas (Hu et al., 2003).
However, MSCs from bone marrow have been more thoroughly characterized than any other
type of MSC most likely due to accessibility. Obtaining this tissue requires a relatively
uncomplicated yet painful procedure. Adipose tissue, on the other hand, represents a tissue
source that is extremely abundant (i.e., via discarded lipoaspirate tissue), readily accessible,
results in minimal patient discomfort and yields high enough cell numbers to sufficiently and
efficiently expand cell populations.
Isolation Procedures
Martin Rodbell is accredited with the first description for the isolation of adipose tissue
from rats in 1964 (Rodbell, 1964). Briefly, the procedure involved the removal of tissue, fine
mincing and exposure to, at the time, a commercially available crude preparation of collagenase
(Type I). The digested tissue was then subjected to multiple centrifugation steps yielding the
separation of floating cells, which were adipocytes, from the pelleted, heterogenous stromal-
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vascular fraction (Rodbell, 1964). Several research groups since then, including Van and
Roncari, Deslex et al. and Hauner et al., have shown that the isolated fraction of cells contains
plastic-adhering adipocyte precursors (Deslex et al., 1987; Hauner et al., 1989; Van and
Roncari, 1977). Modified versions of this protocol have been adapted for the isolation of
adipocyte precursors or adipose-derived stem cells (ASCs) from the rat, mouse, pig, horse and
human. Human adipose tissue has been obtained through processed liposuction aspirates,
which are discarded in a typical procedure (Deslex et al., 1987; Hauner et al., 1989; Lalikos et
al., 1997; Moore et al., 1995; Van and Roncari, 1977). Obtaining ASCs from liposuction
aspirates is beneficial in that it bypasses several steps in the original procedure.
ASC Characterization: Immunophenotype
Due to the easy access to human adipose tissue described above, much of the research
investigating the immunophenotype of ASCs has been performed in the human. Previously
stated, MSCs are positive for multiple cluster differentiation molecules such as CD73, CD105
and CD90 and negative for CD11b, CD14, CD45 and HLA-DR. The presence, or absence, of
these markers was consistent for the human ASC cell surface. Other positive antigens include
CD9, CD29, CD44, CD49, CD166, osteopontin, osteonectin, vimentin, HLA-ABC and various
others (Table 2.1) (Aust et al., 2004; Gimble et al., 2007; Gronthos et al., 2001; McIntosh et al.,
2006; Mitchell et al., 2006; Zuk et al., 2002). Human ASCs produced additional negative results
for CD16, CD18, CD31, CD50, CD56, CD62 and CD104 (Table 1)(Aust et al., 2004; Gimble et
al., 2007; Gronthos et al., 2001; McIntosh et al., 2006; Mitchell et al., 2006; Zuk et al., 2002).
ASC Characterization: Differentiation
In addition to the determination of the phenotypic landscape, the differentiation capacity
must be evaluated to further characterize ASCs. Vidal et al. (2007) determined the
multipotentiality of equine ASCs. Following adipogenesis induction, accumulation of oil droplets
by Oil-red-O staining along the periphery of preadipocytes was noted followed by the formation
of fat globules by day 2 following induction (Vidal et al., 2007). In addition to adipogenesis, the
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Tabe 2.1. Immunophenotype of Passaged Human ASCs
Antigen Category
Adhesion molecules

Surface-Positive Antigens
CD9 (tetraspan), CD29 (!1 integrin), CD49 days ("4 integrin), CD54
(ICAM-1), CD105 (endoglin, CD166 (ALCAM)

Surface-Negative Antigens
CD11b ("b integrin), CD18 (!2 integrin), CD50 (ICAM-3),
CD56 (NCAM), CD62 (E-selectin), CD104 ("4integrin)

Receptor molecules

CD44 (hyaluronate), CD71 (transferrin)

CD16 (Fc receptor)

Enzymes

Extracellular Matrix
molecules
Cytoskeleton
Hematopoietic
Complement cascade
Histocompatibility
Antigen
Stem Cell
Stromal

CD10 (common acute lymphocytic leukemia antigen), CD13
(aminopeptidase), CD73 (5’ ecto-nucleotidase), aldehyde
dehydrogenase
CD90 (Thy-1), CD146 (Muc18), collagen types I and III,
osteopontin, osteonectin
"-smooth muscle actin, vimentin
CD14, CD31, CD45
CD55 (decay-accelerating factor), CD59 (protectin)
HLA-ABC

HLA-DR

CD34, ABCG2
CD29, CD44, CD73, CD90, CD166

(Gimble et al., 2007)
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osteogenic potential was demonstrated in these equine ASCs by the presence of calcium
minerlization through alizarin red positive calcium phosphate nodule formation (Vidal et al.,
2007). Human ASCs have been more extensively characterized in terms of differentiation
potential and have been shown to successfully respond to chondrogenic, osteogenic, myogenic,
adipogenic and neurogenic conditions. The presence of TGF-!, ascorbate and dexamethosone
in the ASC culture environment will induce the expression of chondrogenic proteins including
collagen Type II, Type IV and aggrecan (Awad et al., 2003; Erickson et al., 2002; Wickham et
al., 2003). Although culture components are similar to those in chondrogenic inducing
conditions, osteogenesis marked by calcium phosphate mineralization within the extracellular
matrix will ensue with the inclusion of ascorbate, dexamethasone, in addition to !glycerophosphate (Halvorsen et al., 2000; Halvorsen et al., 2001b). Finally, an induction
cocktail consisting of insulin, methylisobutylxanthine, dexamethasone and indomethacin will
cause ASCs to form lipid-filled vacuoles that secrete leptin and lipoprotein lipase (Halvorsen et
al., 2001a; Hauner et al., 1989; Zuk et al., 2001).
ASCs as Donor Cells for Nuclear Transfer
Currently, nuclear transfer results in relatively low success rates and research has
reported substantial problems with the welfare of some of the cloned animals produced.
Developmental abnormalities observed following nuclear transfer include low pregnancy rates,
high percentages of loss during early and late pregnancy, stillbirths, early postnatal deaths,
short life-span, obesity and malformations. These abnormalities make up what is referred to as
Large Offspring Syndrome or LOS and may be caused by several factors, such as using an
inappropriate donor cell and/or recipient oocyte, the inability to properly synchronize the cell
cycle phase of the donor nucleus and the recipient cytoplasm, inadequate reprogramming of the
donor genome, inappropriate handling of oocytes, somatic cells and embryos during maturation,
and/or subjection of these cells to the various necessary manipulations and cultural techniques
which could result in cellular stresses (Young et al., 2001).
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Epigenetic Modifications and Nuclear Transfer
Much research has focused on the epigenetic modifications of DNA and their role in
embryonic development. In the production of a normal developing embryo, the oocyte (arrested
at metaphase II) is united with a sperm where it completes meiosis and extrudes the second
polar body. The embryo contains a subset of cells that remain totipotent (can support
differentiation into all cell types) for the first one to two cell divisions (Kono, 1997). The following
cleavage events undergo DNA modifications, which render them unable to form all tissue types
and once initiated the series of events proceeds beyond the point of no return. However,
exposure of a donor cell’s chromatin to ooplasm as in nuclear transfer will redirect the
programming of the donor nucleus to mimic that of a zygotic nucleus as in normal fertilization
(Figure 2.1) (Kikyo and Wolffe, 2000). The oocyte virtually erases the epigenetic modifications
imposed on the genome during differentiation and reinstates totipotency (Kikyo and Wolffe,
2000). The reprogramming of the donor cell nucleus is essential to initiate and complete
embryonic development.
Fusion with embryonic stem cells provides an alternative method for inducing nuclear
reprogramming of somatic nuclei. Factors within the embryonic stem cell, much like in the
unfertilized oocyte, render a resultant hybrid cell, which demonstrates pluripotent competence
by differentiation into multiple cell lineages and expression of tissue-specific genes (Cowan et
al., 2005; Tada et al., 2001). Several somatic cell types have been successfully reprogrammed
upon fusion with embryonic stem cells including thymocytes (Tada et al., 2001), human
fibroblasts (Cowan et al., 2005) and human myeloid precursor cells (Yu et al., 2006). Research
indicates that the nuclear compartment of the embryonic stem cell houses the reprogramming
capability because fusion of karyoplasts and not cytoplasts generate the reprogrammed hybrid
(Do and Scholer, 2004). These reprogrammable epigenetics govern the regulation of repression
of genes not necessary in cell types at specific developmental stages while preserving the DNA

31

Figure 2.1 Epigenetic reprogramming of methylation/demethylation patterns in preimplantation
embryos. The paternal genome (blue line) is demethylated immediately following fertilization via
active demethylation whereas the maternal genome (red line) is demethylated through passive
mechanisms shortly after. The event of demethylation in nuclear transfer embryos (black line) is
not believed to undergo complete erasure compared to the levels achieved by maternal and
paternal genomes (Modified from Reik et al., 2001).
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sequence (Wolffe and Matzke, 1999). Epigenetic modifications during the reprogramming
process following nuclear transfer include DNA methylation and posttranslational acetylation,
phosphorylation, and methylation of histone amino termini that function to modulate chromatin
structure, which ultimately regulates transcriptional activation or repression of specific genes.
Acetylatable lysine residues in the N termini of histone H3 (such as K9, K14, K18, and K23) and
H4 (such as K5, K8, K12, and K16) and methylatable lysine residues in H3 (such as K4,
K9,K27, K36, and K79) and H4 (K20) are the most relevant that have been identified (Kimura et
al., 2004). Histone acetyltransferases (HATs) are the enzymes responsible for the transfer of
acetyl groups to lysine residues and histone deacetylases (HDACs) dictate their removal.
Acetylation neutralizes the positive amino acid charge decreasing the affinity for DNA. The
termini displace from the nucleosome increasing accessibility of transcription factors, which
leads to gene expression (Grunstein, 1997).
Alternatively, cytosine methylation demarcates or “imprints” portions of DNA in order to
distinguish between silenced and expressed genes of parental alleles (Cezar, 2003). Generally,
DNA methylation blocks transcription factors from binding methylated sequences and is
associated with transcriptional silencing and imprinting (Hiendleder et al., 2004b). For example,
H19, insulin-like growth factor II, and the insulin-like growth factor II receptor all display
alternative DNA methylation patterns based on the inheritance of the allele either from the
sperm or the oocyte (Kono, 1997). In nuclear transfer, genes normally expressed during
embryogenesis are silent in somatic donor cells and must be turned back on. Therefore, the
DNA methylation patterns must be reorganized to resemble that of undifferentiated nuclei
(Rideout et al., 2001) (Figure 2.1). LOS and other phenotypic abnormalities may be a result of
improper expression of imprinted genes as a result of reorganized DNA methylation (Kono,
1997).
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Epigenetic Regulation of Pluripotency
The initial epigenetic landscape of the DNA sequence determines the pluripotent
capabilities of the cell. Embryonic stem cells possess transcriptionally active chromatin that is
structured in an open configuration containing an abundance of acetylated lysine residues
(Boyer et al., 2006). However, as the cell commits to a differentiation pathway, acetylated
histone modifications decrease, heterochromatin formation ensues, and pluripotential declines
(Meshorer and Misteli, 2006; Meshorer et al., 2006).
Regulators of development in undifferentiated cells are suggested to be silenced by the
presence of a bivalent domain modification pattern in which a large region of histone H3 lysine
27 trimethylation (H3K27me3) harbors smaller regions of histone 3 lysine 4 trimethylation
(H3K4me3) (Bernstein et al., 2006). Important to the maintenance and pluripotency of stem
cells Polycomb-group proteins catalyze the H3K27me3 modification and Trithorax group
proteins catalyze the H3K4me3 modification (Bernstein et al., 2006). The dual marks contain
both repressive (H3K27me3) and activating (H3K4me3) modifications, which work to silence
developmental genes in embryonic stem cells while simultaneously keeping them poised for
activation. As the cell differentiates, the bivalent conformation resolves where H3K4me3
activating marks permit early-replicating gene expression in lineage-committed cells and
H3K27me3 repressing marks block late-replicating gene expression in lineage-committed cells
(Boyer et al., 2006; Meshorer and Misteli, 2006).
Also of note, these developmental regulators contain highly conserved non-coding
elements, which contain a wealth of H3K27me3 and H3K4me3 containing bivalent domains
(Bernstein et al., 2006). These regions house genes responsible for encoding several
transcription factors which function to maintain and regulate pluripotency and self-renewal in
both early embryos and embryonic stem cells (Bernstein et al., 2006). These factors include the
POU (Pit/Oct/Unc) domain-containing protein Oct-4 (also known as Pou5fl) (Nichols et al., 1998;
Niwa et al., 2000; Rosner et al., 1990; Scholer et al., 1990a; Scholer et al., 1990b), the high
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mobility group (HMG)-box protein Sox-2 (Avilion et al., 2003), and the homeoprotein Nanog
(Chambers et al., 2003; Mitsui et al., 2003). These three transcription factors function through
very distinct pathways that are thought to converge to dictate early cell fate decisions (Boyer et
al., 2006). Recently, the conservation of these proteins among mammalian species has
become apparent and Oct-4, Sox-2 and Nanog are considered markers of cells that have
pluripotent capabilities. Also, their association with highly conserved non-coding elements
suggests a conserved role for the bivalent chromatin domains mentioned above (Bernstein et
al., 2006).
At this time, research has not identified bivalent domains in adult somatic MSCs from
porcine adipose tissue. Analysis of these cells may reveal global methylation and/or acetylation
patterns similar to their embryonic stem cell counterparts. Further characterization of porcine
ASCs in this manner could assist the isolation and purification of a population of MSCs from the
easily obtainable tissue of adipose that can later be tested as donor cells in nuclear transfer.
Somatic cells used as donor cells in nuclear transfer typically produce more blastocyst stage
embryos compared to embryos derived from embryonic stem cells (Rideout et al., 2001). About
60% of embryonic stem cells are in S-phase when used as donor cells (Rideout et al., 2001).
S-phase embryonic stem cells are exposed to high levels of maturation promoting factor, which
induces premature nuclear envelope breakdown and chromosome condensation. Cells likely
undergo a second DNA replication cycle activating cell checkpoint mechanisms ultimately
leading to inappropriate ploidy and cell cycle arrest. However, more embryonic stem cell
nuclear transfer embryos develop to term than somatic cell nuclear transfer embryos (Rideout
et al., 2001). Although nuclear transfer clones produced from either embryonic stem cells or
somatic cells demonstrate similar phenotypic abnormalities, term embryonic stem cell nuclear
transfer clones indicate that utilization of a less differentiated donor cell may be more
acquiescent to appropriate reprogramming (Rideout et al., 2001).
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Our laboratory has contributed to the characterization of porcine ASCs by: (1) the
development of an isolation and culture procedure for both undifferentiated and differentiated
(adipocytes, osteocytes, and chondrocytes) ASCs, (2) the definition of ASC growth
characteristics such as cell cycle length, population doublings, (3) the confirmation of cell
surface gene expression in both differentiated and undifferentiated ASCs, (4) the analysis of
clonal capacity followed by differentiation potential in ASCs, (5) the determination of
chromosomal stability through in vitro culture, (6) the analysis of stem cell surface markers
through in vitro culture, (7) the detection of methylated DNA and acetylated histone H3 through
in vitro culture, (8) the determination of expression patterns of chromatin remodeling proteins,
and (9) the presence/absence of bivalent chromatin structures. Our overarching hypothesis is
that low development rates observed following porcine nuclear transfer are a result of
incomplete reprogramming of the donor cell nucleus and that somatic stem cells or those cells
which demonstrate stem-like characteristics (i.e. ASCs) will be reprogrammed more completely.
The new information will aid the efficiency of isolation and purification of a population of MSCs
from the easily obtainable tissue of porcine adipose that can later be tested as donor cells in
nuclear transfer.
Conclusions
Cutting edge methods for producing transgenic animals still need much improvement
considering the inefficiency and expenses involved. By employing cells such as somatic stem
cells or cells demonstrating stem-like characteristics as donor cells for nuclear transfer, resultant
anomalies such as those that classify Large Offspring Syndrome may be averted and increase
the success rates of nuclear transfer. Controversy associated with the use of human tissues
necessitates the development of an animal model to continue research in this important area.
Many treatments have already resulted from the use of tissues generated through
advancements made in the porcine animal model. Therefore, the definition of stem cellular
characteristics will aid in the efficient identification and isolation of a population of MSCs from
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porcine adipose tissue to be later used as donor cells in nuclear transfer creating an important
animal model for additional future biomedical applications.
Currently, nuclear transfer utilizing a true MSC as the donor cell is unconvincing most
likely due to inefficient isolation/purification protocols and characterization. Based on the
success of our preliminary experiments, we further defined cellular characteristics of MSCs
derived from adipose tissue of the porcine animal model. Knowledge of the true nature and
potential of MSCs will aid their contributions to medical treatments. The use of a less
differentiated donor cell may be more conducive to appropriate reprogramming (Rideout et al.,
2001) leading to an increased success rate in nuclear transfer which will ultimately lend to the
enhancement of the number of live transgenic offspring produced. An increased efficiency will
also shorten the time required to produce an adequate number of live transgenic offspring for
pharmaceutical and other biomedical purposes and therefore decrease the ultimate cost of
production. In turn, this will eliminate economic barriers currently blocking the application of this
technology from commercial large-scale production of transgenic animals and therefore make
transgenic animals a more appealing method of producing recombinant proteins.
Researchers in industry are engineering bacteria or mammalian cells into bioreactors for
producing recombinant proteins for therapeutic treatments. However, these tiny bodies are
incapable of producing the necessary mass quantity to adequately service the growing demand.
The current shortfall hinders such therapeutic products from entering the marketplace thereby
preventing patient access to new therapies, which in turn denies revenue to pharmaceutical
companies who have invested large sums of money in product development. An increase in the
efficiency of transgenic animal production will provide a substitute factory for the manufacture of
these recombinant proteins and offer a more cost effective mechanism for the production of
large quantities (i.e., kilograms).
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CHAPTER III
ISOLATION AND CHARACTERIZATION OF PORCINE ADIPOSE TISSUE-DERIVED ADULT
STEM CELLS
Introduction
Stem cell applications for biomedical treatments continue to face many challenges
concerning the originating source, expansion and culture, and differentiation. The controversy
surrounding the use of stem cells from embryos has encouraged research of alternative stem
cell sources. Numerous efforts have focused on the isolation and characterization of adult stem
cells. By definition, stem cells must be able to self-renew as well as differentiate into multiple
tissue phenotypes. Adult stem cells can be found among differentiated tissues. Adult stem
cells can renew themselves and when removed from their niche they are able to differentiate
into the multiple cell types surrounding them in order to maintain and repair that tissue or organ.
The development of an animal stem cell model will enhance important biomedical treatments,
such as tissue engineering and cord blood stem cell transplants utilized in human patients.
Mesenchymal stem cells (MSCs) are adult stem cells and have been isolated from many
different mesodermal tissues including bone marrow (Friedenstein et al., 1976), fat (Rodbell,
1966; Rodbell and Jones, 1966) and cord blood (Broxmeyer et al., 1992). MSCs are pluripotent
precursors that support hematopoiesis and formation of bone tissue, cartilage and adipose
tissue (Friedenstein et al., 1976; Halvorsen et al., 2000; Gimble and Guilak, 2003). The inherent
ability of MSCs to proliferate in vitro and maintain their pluripotency makes them attractive
candidates for the development of an animal stem cell model.
MSCs have been isolated from various tissues based on their ability to adhere to plastic
and their morphology similar to that of fibroblasts (Luria et al., 1971; Kassem et al., 1993;
Rickard et al., 1996). However, hematopoietic cells contaminate MSCs creating a
heterogenous population of cells in culture. Cell surface markers, such as CD9, CD10, CD13,
CD29, CD34, CD44, CD49 d, CD49 e, CD54, CD55, CD59, CD105, CD106, CD146, CD166
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(Gronthos et al., 2001), SSEA-4 (Gang et al., 2007) and a combination of others, have been
utilized to identify and isolate MSCs from these contaminating hematopoietic cells as well as to
further characterize MSCs. Gene and protein expression profiles have been defined in some
human bone marrow and adipose tissue-derived MSC populations showing the presence of
these cell surface markers (Simmons and Torok-Storb 1991; Barry et al., 1999; Gronthos et al.,
2001). In addition to cell surface markers, another important characteristic used to distinguish
MSCs from hematopoietic cells is their ability to support differentiation into several different cell
types depending on culture conditions.
Human adipose tissue-derived adult stem (ASCs) cells are self-renewing, can be
differentiated into multiple tissue lineages and exhibit a high expression level of CD34, CD44
and other stem cell markers (Gronthos et al., 2001; Guilak et al., 2006). At this time, these stem
cell characteristics have not been identified in porcine ASCs. In the present study, a protocol
has been developed for the isolation and culture of porcine ASCs. Growth characteristics
including population doublings, cell cycle length and proliferative capacities have been
determined. We also examined these stem cell-like cells for the capacity to self-renew and
differentiate into cell lineages.
Materials and Methods
All reagents were purchased from Sigma (St. Louis, Mo., USA) unless otherwise stated.
Establishment of Primary Cultures
Subcutaneous fat (10 g per pig) was harvested from the dorsal abdominal area in
mature female crossbred domestic pigs (n = 5) between the age of 6 months and 1 year of age
at a local abattoir. Samples were transported on ice in Dulbecco’s phosphate-buffered saline
(dPBS; Gibco, Grand Island, N.Y., USA) containing 200 U/ml of penicillin and 200 !g/ml of
streptomycin (Gibco) and 2.5 !g/ml of Fungizone (Gibco). The tissue was finely minced and
washed with dPBS containing P/S and Fungizone. Each sample was digested with an equal
volume of 0.1% collagenase Type I (240 IU/ml; Gibco) in dPBS with 1% bovine serum albumin
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in a shaker incubator rotating at 200 rpm at 39° C for 2 hours. The cell suspension was filtered
through a dual filter system comprised of two nylon net filters (20 and 180 !m; Millipore,
Bedford, MA, USA). Adipocytes were separated from the stromal-vascular fraction by
centrifugation at 1,200 rpm for 5 minutes. Cells were then stained with Hoechst 33342 (2 !g/ml)
to determine the number of nucleated cells in the suspension. Cells were plated at 6,700
nucleated cells/cm2 in 10 ml of expansion medium containing Dulbecco’s modified Eagle
medium (DMEM; Hyclone, Logan, UT, USA) with high glucose supplemented with 10% fetal
bovine serum (FBS; Hyclone), 100 U/ml of penicillin and 100 !g/ml of streptomycin and 2.5
!g/ml of Fungizone in a 75-cm2 culture flask and incubated at 39°C in 5% CO2.
Cell Culture Maintenance
Fresh medium was supplied every 3 to 4 days. At 70 to 90% confluence, adipose cells
were passaged by trypsinization, counted using a hemacytometer and re-seeded at an initial
concentration of 6,700 cells/cm2. Population doublings were calculated at each passage using
the following equation: log (final concentration/initial concentration) x 3.33 (Arat et al., 2006).
Also, cell cycle length was calculated based on the following equation: number of days in
culture/population doublings. Cells were passaged until replicative senescence was observed.
Replicative senescence was observed when the cells ceased to divide and was defined by a
change in morphology from an elongated, spindle like to flattened, irregular shape with
dispersed cytoplasm and the appearance of cytoplasmic vacuoles.
Cloning Capacity Procedures
Cells were isolated according to the above procedure and plated from the initial culture
(passage 0) at approximately 5 cells/cm2 in 10 ml of expansion medium in a 100-mm culture
dish and incubated at 39°C in 5% CO2. Adherent cells formed colonies after 10 days in culture
and were selected for ring cloning (passage 0) based on the following criteria: colonies
contained at least 100 cells and colonies were located a minimum of one microscopic field from
all other colonies. Cells were passaged by trypsinization and re-seeded in a 1.9-cm2 culture
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dish (passage 1) and at 70 to 90% confluence passaged into a 9.62-cm2 culture dish (passage
2), a 25-cm2 culture flask (passage 3) and a 75-cm2 culture flask (passage 4).
Differentiation of Primary Cultures and Clones
At 70 to 90% confluence (following passage 4 for clones), cells were passaged by
trypsinization and cultured for 21 days in culture medium previously demonstrated to induce
differentiation (Zuk et al., 2002; Gimble and Guilak, 2003). Culture media were changed every
3 to 4 days throughout the study. For adipogenesis, cells were cultured on days 1 to 4 in
differentiation medium containing DMEM supplemented with 3% FBS, 100 U/ml of penicillin and
100 !g/ml of streptomycin, 2.5 !g/ml of Fungizone, 10 ng/ml of insulin, 10–9 M, dexamethasone,
250 !M isobutyl methylxanthine and 0.2 mM indomethacin. Culture medium beyond day 4
contained DMEM with 3% FBS, 100 U/ml of penicillin and 100 !g/ml of streptomycin, 2.5 !g/ml
of Fungizone, 10 ng/ml of insulin and 10–9 M dexamethasone.
For chondrogenesis, cells were cultured for the duration of differentiation
in medium containing DMEM with 10% FBS, 100 U/ml of penicillin and 100 !g/ml of
streptomycin, 2.5 !g/ml of Fungizone, 6.25 !g/ml of insulin, 10 ng/ml of transforming growth
factor-" and 10–9 M dexamethasone.
For osteogenesis, cells were cultured in differentiation medium containing DMEM with
10% FBS, 100 U/ml of penicillin and 100 !g/ml of streptomycin, 2.5 !g/ml of Fungizone, 10 mM
" -glycerophosphate, 50 ng/ml of ascorbic acid and 10–9 M dexamethasone.
Histological staining techniques were used to determine differentiation. Nile Red, a stain,
which detects intracellular lipid accumulation, was used to determine adipocyte differentiation.
Safranin O was utilized to identify glycosaminoglycans in the extracellular matrix of
differentiated chondrocytes. After osteogenic induction, Alizarin Red S was employed to detect
mineralized calcium deposition.
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Experimental Design
Cell lines were defined as cells isolated from a single porcine donor Five cell lines were
cultured and population doublings and cell cycle length were calculated at each passage
(except for clones). Cells were trypsinized and re-seeded at 30 to 40% confluence to avoid
contact inhibition and possible differentiation. Passaged lines were cultured until 70 to 90%
confluence was reached. Two replicates per cell line were performed for establishing growth
characteristics and one replicate per cell line was performed for cloning procedures.
Results
Isolation of Cell Lines
Porcine adipose tissue-derived adult MSC lines were successfully established from 5
female pigs. The average number of mononuclear cells was 2.7 x 106/10 g for each fat tissue
sample. Of those mononuclear cells, an estimated 26% adhered to the plastic surface of the
culture vesicle, while the rest were removed during the first medium change after the first 24
hours of culture. Adherent cells began forming colonies beginning on day 1 after the primary
culture was established. Most cells in culture demonstrated an elongated, spindle-like
fibroblastic morphology (Figure 3.1, black arrow), while others displayed a more rounded
appearance (Figure 3.1, white arrow). Cell cultures expanded rapidly to 70 to 90% confluence
by days 8 to 10 after initial seeding.
Growth Characteristics
Population doublings were calculated following the first passage according to the
calculation described above. From two cell lines, two replicates of each line were analyzed in
parallel. Cumulative population doublings were measured for each replicate with a mean of 29
population doublings without reaching replicative senescence (Figure 3.2 A). Average cell cycle
lengths for adherent, undifferentiated cells were recorded throughout the duration of the culture
interval. Cells completed one cell cycle approximately every 3.3 days (Figure 3.2 B). Cells did
not reach replicative senescence by the end of this study (100 days).
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Figure 3.1. Undifferentiated stromal cell morphology. Discrete colonies demonstrating spindlelike fibroblastic morphology adhered to plastic within 24 hours of initial seeding. Most cells
displayed a characteristic elongated shape (black arrow), while others had a more rounded
appearance (white arrow). Magnified using a 20X objective.
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A.

B

B.

Figure 3.2. Proliferative characteristics of undifferentiated stromal cells: 1 and 2 represent each
cell line while A and B are replicates. (A) Average cell cycle lengths were recorded throughout
the duration of culture. (B) Proliferative capacity indicates cells have not reached observed,
replicative senescence.
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Clonal Analysis of Porcine ASCs
A total of 16 clones were selected for ring cloning from each of 2 donor pigs and 15 from
the 3rd donor resulting in 47 attempted clones selected in all. Of the 47 clone attempts, 8 did
not produce a clone for passage 1 (17.0%) and replicative senescence was observed in 12 of
47 clones (25.5%). There were 7 (43.7%) surviving clones produced from the first donor that
were successfully cultured to passage 4, the second donor produced 10 (62.5%) and there were
14 (87.5%) from the third donor. Cloned colonies expanded in a monolayer maintaining a
fibroblastic morphology throughout the culture interval. Of the 31 cloned colonies that survived
to passage 4 without reaching replicative senescence or acquiring contamination, 19 colonies
(62.0% of the total cloned population) were subjected to multiple cell lineage differentiation
analysis (Table 3.1).
Cell Lineage Differentiation of Cloned Porcine ASCs
Clonal cell cultures were exposed to differentiation conditions. On day 21 of
differentiation, stains specific for characteristics of differentiated adipocytes, osteocytes and
chondrocytes were utilized. Nile red, a stain which detects intracellular lipid accumulation, was
used to determine adipocyte differentiation. After chondrogenic induction, safranin O was used
to detect glycosaminoglycans in the extracellular matrix. Alizarin red S identified mineralized
calcium deposition in differentiated osteocytes. After 21 days of culture in differentiation
medium, a qualitative estimate was assigned to each differentiation condition based on multiple
fields of view.
Of the 19 cloned colonies subjected to differentiation conditions, 92% of colonies
differentiated under adipogenic conditions stained positive for intracellular lipids (Figure 3.3 A)
and the undifferentiated control cells displayed expression of these intracellular lipids, only less
intensely (Figure 3.3 C). Chondrogenic induction was detected in 97% of cloned colonies by the
presence of glycosaminoglycans in differentiated clones (Figure 3.3 E). This was also noted in
undifferentiated cell populations, but again less intensely (Figure 3.3 F). Finally, osteocyte
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Table 3.1. Number of surviving porcine clones to passage 4 and differentiation
†

P1

P2

P3

P4*

Diff culture

I

16

16

12

12

7

0

0 (0%)

0 (0%)

0 (0%)

II

16

16

13

13

10

5

10/10 (100%)

10/10 (100%)

10/10 (100%)

III

15

15

14

14

14

14

25/28 (89%)

27/28 (96%)

28/28 (100%)
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Chondrogenesis

†

Total # clones

P Passage; Diff = Differentiated.
*Approximately 14 population doublings or 4-8 weeks in culture.
†
Two replicates.

Adipogenesis

†

Cell line

Osteogenesis

Figure 3.3. Differentiation of P4 clones. Adipogenic differentiation stained positive with Nile
Red staining; viewed with a FITC filter (A) and phase contrast (B). Undifferentiated stromal cells
(control) demonstrated only slight Nile Red staining (Panel C-FITC filter and Panel D-phase
contrast). Chondrogenic induction was detected by Safranin O in differentiated clones (E) and
less intensely in undifferentiated cell populations (F). Osteocyte differentiation was observed
only in induced cells (G) and not in undifferentiated stromal cells (H). Images A-F and H were
magnified using a 20X objective while image G was magnified using a 40 X objective.
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differentiation was observed in 100% of cloned colonies. Positive staining for calcium
deposition was observed only in the induced cells (Figure 3.3 G) and not in the undifferentiated
stromal cells (Figure 3.3 H).
Discussion
Stem cell biology has applications in regenerative medicine for repairing, replacing or
regenerating diseased tissues and organs. Stem cells must have the capacity for self-renewal
and must have the ability to give rise to differentiated cell types to be considered ‘stem cells’.
The use of somatic or adult stem cells, found in adult tissues, escapes the controversy
associated with the use of stem cells derived from embryos and fetal tissues. Also, adult stem
cells have the potential to elude immunological rejection and disease contraction when
transplanted back into the donor (Merok et al, 2001). The advancement of stem cell technology
is already contributing to applications, such as gene therapies for disease and the development
of research techniques, such as bone marrow transplants and transgenic mice (Merok et al.,
2001).
The emerging concept of plasticity (also known as transdifferentiation) in stem cells
suggests that somatic stem cells have the ability to dedifferentiate from their source cell type
and then differentiate into new cell types (Guilak et al., 2004). The improvement of culture
conditions and the definition of cellular characteristics for the efficient isolation and purification
of a population of MSCs from multiple species-specific tissues will likely create important animal
models for additional biomedical applications.
At this time, knowledge of the optimal culture conditions for pluripotent and differentiated
MSCs from adipose, bone marrow and cord blood is limited. Also, culture characteristics of
these cells have not been clearly defined and studies generating gene and protein expression
profiles are underway, but remain inconclusive. This study has developed a successful protocol
for the isolation and culture of porcine ASCs. We were able to establish primary MSC lines from
5 female pigs isolating an average of 2.7 x 106 MSCs/10 g from each fat tissue sample. Similar
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quantities of cells have been isolated from adipose tissue of rhesus monkeys and humans
(Izadpanah et al., 2006; Oedayrajsingh-Varma et al., 2006). Of the cells isolated, an estimated
26% adhered to the plastic surface of the culture vesicle. Most cells in culture displayed an
elongated, spindle-like fibroblastic morphology. Cells were plated at a density of
6,700 cells/cm2, while lower concentrations did not render rapid colony cultivation (data not
shown), suggesting that the cells prefer to have neighboring cells within a closer range. Growth
characteristics of these MSCs indicate that a mean of 29 population doublings could be reached
without replicative senescence. These cells completed one cell cycle approximately every 3.3
days and had not yet reached replicative senescence by the end of this study (100 days).
In comparison, Zuk et al. (2001) described human adipose tissue to harbor
approximately 2–6 x 106 cells per 300 ml of processed lipoaspirate which can be maintained in
culture through passage 13 (approximately population doubling 22) or 165 days. Human ASCs
isolated by resection or tumescent liposuction demonstrate a cell cycle length of approximately
1.5–2.8 days (Zuk et al., 2001; Oedayrajsingh-Varma et al., 2006). Also, human adipose tissue
isolated using these techniques contained adherent cells representing 1.9 to 6.3% of the total
cellular population (Oeday rajsingh-Varma et al., 2006). Porcine bone marrow derived MSCs
can be isolated with a yield of approximately 2.3 x 108 cells per 20 ml bone marrow aspirate
(Bosch et al., 2006). Plating 500 bone marrow-derived cells per cm2 renders approximately
4,000 cells per cm2 after 3 to 4 days in culture (estimating a cell cycle length of 0.75 to1 day)
(Zeng et al., 2006). Also, these cells can be cultured for more than 100 population doublings
(Zeng et al., 2006). Based on these findings, growth characteristics of the porcine ASCs used
in this study demonstrate similar results.
Clonal analysis indicates that these stem cell-like cells have the capacity to self-renew
and differentiate into cell lineages much like human ASCs (Guilak et al., 2006). We hypothesize
that the observed replicative senescence in these cloned colonies is a result of the cellular
cloning processes because primary cultures did not exhibit this phenomenon. Colonies
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subjected to adipogenic, chondrogenic and osteogenic differentiation conditions all stained
positive. While undifferentiated controls (approximately population doubling 30) stained positive
for adipogenesis and chondrogenesis, it is evident that the colonies subjected to differentiation
conditions stained much more intensely than colonies that were not subjected to differentiation
conditions.
Improved culture conditions and defined cellular characteristics of these porcine ASCs
have been identified. The techniques used in this study will increase the efficiency of isolation
and purification of a population, of stem cell like cells from easily obtainable tissues. The
isolation and characterization of a somatic stem cell population from a model animal, such as
the pig, could prove valuable in tissue engineering research. The availability of such an animal
model will be very beneficial in determining the true efficacy of somatic stem cell tissue,
regeneration versus the use of embryonic stem cells.
* This is a reprint of an article published in Cells Tissues Organs, Williams KJ, Picou AA, Kish
SL, Giraldo AM, Godke RA, Bondioli KR. Isolation and characterization of porcine adipose
tissue-derived adult stem cells. 188(3):251-258, with permission from S Karger AG, Basel.
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CHAPTER IV
CELL SURFACE CHARACTERIZATION AND KARYOTYPIC ANALYSIS OF PORCINE
ADIPOSE-DERIVED STEM CELLS
Introduction
Over the last twenty years, human bone marrow stromal cells have been shown to
differentiate along adipocyte, osteocyte and other mesodermal pathways as well as support the
proliferation of hematopoietic stem cells. It has been shown that specific adhesion molecules
expressed on the surface of bone marrow stromal cells mediate the cell-cell interactions
supporting differentiation and proliferation (Kincade et al., 1988). The presence of these
molecules may be utilized in isolation protocols to identify and enhance the purification of a
population of cells within a heterogeneous population.
Human adipose tissue is an alternative source of multipotent stromal cells, which is
largely derived from processed liposuction aspirates. Human and porcine adipose tissue–
derived adult stem cells (ASCs) are a self-renewing population of cells with a multilineage
plasticity similar to bone marrow–derived mesenchymal stem cells (MSCs) and show promise
for use in combination with various biomaterials for reconstructive tissue engineering (Halvorsen
et al., 2001a; Hauner et al., 1989; Williams et al., 2008). The phenotypic profile of human ASC
surface proteins has been partially characterized for stem cell-associated cluster differentiation
molecules including CD9, CD10, CD13, CD29, CD31, CD34, CD44, CD49a CD49d, CD49e,
CD54, CD55, CD59, CD63, CD73, CD90, CD105, CD106, CD144, CD146, CD166 (Gronthos et
al., 2001; Mitchell et al., 2006), and for SSEA-4 (Gang et al., 2007), ABCG2, ALDH, VEGFr-2
(Mitchell et al., 2006) and a combination of other molecules. However, the surface protein
phenotype has not been described for porcine ASCs at this time.
Multiple research groups have characterized human ASCs by describing the surface
phenotype, however, there are many subtle discrepancies throughout the literature. The effects
of these differences on the identity of these cells remain unknown. Various factors may play a
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role in producing these inconsistencies. For example, porcine ASCs are isolated from fat
depots likely different from human ASC liposuction aspirates. Also, the age of the donor may be
different and cause the results to disagree. In addition, different isolation procedures, the
specific cell seeding density, differences in culture media, culture duration, the cell cycle, the
passage numbers analyzed, whether the cells were cryopreserved prior to analysis and even
the exposure to plastic (Planat-Benard et al., 2004; Rehman et al., 2004) all may cause
incongruent results. Therefore, it is important to characterize porcine ASCs on the cell surface
level.
The inherent ability of mesenchymal stem cells such as porcine ASCs to proliferate in
vitro and maintain their aptitude for pluripotency (Williams et al., 2008) makes them attractive
candidates as donor cells for more efficient reprogramming during nuclear transfer (NT)
compared to somatic cells currently in use. Studies have however generated contradicting
results for the success of stem cells in NT; for example, skin-derived stem cells increased NT
efficiency (Hao et al., 2009; Zhu et al., 2004) while hematopoietic stem cells did not (Inoue et
al., 2006; Sung et al., 2006). Porcine ASCs have not been tested as donor cells for NT at this
time.
Successful NT in combination with applicable genetic modifications must be conducted
using normal diploid cells before they reach senescence (Denning et al., 2001). Primary cells
utilized to establish culture possess the capacity to survive only a finite number of population
doublings (PDs) before cellular senescence is reached (Hayflick and Moorhead, 1961). As cells
approach this limit, the rate of proliferation decreases (Cameron, 1972) and the probability of
cells to undergo cytokinetic abnormalities and chromosomal alterations increases substantially
(Giraldo et al., 2006; Oback and Wells, 2002). The current techniques employed today to
establish and maintain primary in vitro cell cultures may also be responsible for the induction of
these anomalies (Chu, 1962; Denning et al., 2001; Kasinathan et al., 2001; Oback and Wells,
2002; Rubin, 1997). Spontaneous transformations, which will also influence the success of NT,
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have been described in human and murine adipose tissue-derived MSCs (Rubio et al., 2005)
and have been reported to accumulate proportionally to the time in culture (Oback and Wells,
2002). However, other studies indicate that human bone marrow and adipose tissue-derived
MSCs do not mutate and maintain chromosomal configuration through culture (Bernardo et al.,
2007; Meza-Zepeda et al., 2008).
Porcine ASCs have not been characterized in terms of chromosomal stability through in
vitro culture. Chromosomal aberrations and a limited proliferative capacity of somatic donor
cells cultured in vitro dramatically influence the success of NT (Kasinathan et al., 2001). The
manifestation of genetic modifications in donor cells for NT requires a significant number of PDs
and, unfortunately, these deleterious effects are impossible at this time to circumvent. But the
identification of a donor cell that is genetically stable for a long period of time in vitro may be the
key to increasing the efficiency of NT.
The current study partially characterized the surface protein phenotype of
undifferentiated porcine ASCs in comparison with the immunophenotype of undifferentiated
human ASCs as reported in the literature using flow cytometry and enhanced
chemiluminescence Western blot analysis. Also, the chromosomal stability of porcine ASCs
was determined through in vitro culture in order to further characterize them as potential donor
cells for NT. With a more complete characterization of porcine ASC (i.e. stem cell surface
markers, chromosomal stability) a donor cell population, which can be more efficiently
reprogrammed following fusion with the oocyte, may be identified.
Materials and Methods
All reagents were purchased from Sigma Chemical Co. (St. Louis, MO, USA) unless
otherwise stated.
Establishment of Primary Cultures and Cell Culture Maintenance
Primary cultures were established following procedures previously documented
(Williams et al., 2008). Briefly, 10 g subcutaneous fat was harvested from the dorsal abdominal
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area in mature female crossbred domestic pigs (n = 20) between the ages of 6 months and 1
year of age at a local abattoir. The tissue was finely minced and washed with Dulbecco’s
phosphate-buffered saline (dPBS) containing 200 U/ml of penicillin and 200 "g/ml of
streptomycin (P/S) and 2.5 "g/ml of Fungizone (Gibco). Each sample was homogenized with
an equal volume of 0.1% collagenase Type I (240 IU/ml; Gibco) in dPBS with 1% bovine serum
albumin (BSA) in a shaker incubator rotating at 200 rpm at 39°C for 2 hours.
The cell suspension was filtered through a dual filter system comprised of two nylon net
filters (20 "m and 180 "m; Millipore, Bedford, MA, USA). Cells were then stained with Hoechst
33342 (2 "g/ml) to determine the number of nucleated cells in the suspension. Cells were
plated at 6,700 cells/cm2 in 10 ml of expansion medium containing Dulbecco’s Modified Eagle
Medium (DMEM; Hyclone, Logan, UT) with high glucose supplemented with 10% fetal bovine
serum (FBS; Hyclone), 100 U/ml of penicillin and 100 "g/ml of streptomycin and 2.5 "g/ml of
Fungizone in a 150-cm2 culture flask and incubated at 39°C in 5% CO2.
Fresh medium was supplied every 3 to 4 days. When 70 to 90% confluence was
achieved, the adipose cells were harvested by trypsinization, counted using a hemacytometer
and re-seeded at an initial concentration of 6,700 cells/cm2. Cells were passaged until
replicative senescence was observed.
Stem Cell Surface Protein Immunolabeling
Porcine ASCs were harvested by trypsinization, washed and resuspended in cold PBS
containing 10% FBS and 1% sodium azide. The cells were incubated for 1 hour at room
temperature in primary antibodies (10 "g/ml) to h#-Microglobulin (human, BD Pharmningen,
San Jose, CA, USA, Catalog # 555550), pCD3 (porcine, direct label, BD Pharmingen, San Jose,
CA, USA, Catalog # 559582), pCD8 (direct label, BD Pharmingen, San Jose, CA, USA, Catalog
# 551303), pCD29 (BD Pharmingen, San Jose, CA, USA, Catalog # 552369), pCD44 (Abcam,
Cambridge, MA, USA, Catalog # ab19622), hCD90 (BD Pharmingen, San Jose, CA, USA,
Catalog # 555593) pCD117 (AbD Serotec, Catalog # MCA2598), SSEA-4 (Developmental
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Studies Hybridoma Bank, Iowa City, IA, USA, Raleigh, NC, USA, Catalog # MC-813-70) and
mouse Sca-1 (Ly-6A/E, BD Pharmingen, San Jose, CA, USA, Catalog #557403).
For indirect labeling, cells were then incubated at room temperature for 30 minutes in 10
"g/ml of the Alexa-Fluor® 488 (Invitrogen, Eugene, OR, USA) conjugated secondary antibody.
Cells were counterstained with propidium iodide (50 "g/ml) for 15 minutes. The cells were then
washed and resuspended for flow cytometric analysis at a concentration of 1,000,000 cells/ml in
cold PBS containing 10% FBS and 1% sodium azide.
Flow Cytometric Analysis of Stem Cell Surface Proteins
Samples were analyzed for relative percent positive events for each stem cell surface
proteins using the Accuri® C6 Flow Cytometer® (Accuri Cytometers, Ann Arbor, MI, USA).
Labeled cells were excited with a 488 nm diode laser and a 488 nm diode laser was used to
detect PI levels (FL3-channel). The DNA content derived from the PI levels was used to
distinguish live cells from dead cells in the FL3-channel. Percent positive events for stem cell
surface proteins were detected at >670 nm in the FL1-channel. A gate was established to
exclude non-specific binding as a whole based on secondary antibody only staining. FL3 and
FL1 dot plots were generated using the Accuri CFlow Plus® (Accuri Cytometers) software and
quadrants were instated to distinguish dead from live cells and immunolabeled cells from
unstained cells. Approximately 30,000 to 100,000 events were recorded per sample at early
and late population doublings.
Western Blot Analysis of Stem Cell Surface Proteins
Early PD human (positive control) and porcine ASCs were lysed and proteins extracted
using a solution containing the M-PER® Mammalian Protein Extraction Reagent (Thermo
Scientific, Rockford, IL, USA), HaltTM Protease Inhibitor Single-use Cocktail (Thermo Scientific)
and 10 "l/ml EDTA solution on a rotator for 10 minutes. Cellular debris was removed by
centrifugation at 14,000 x g for 15 minutes. The protein extractions were analyzed by a typical
western blot procedure. Briefly, protein extractions were separated by SDS-polyacrylamide gel
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electrophoresis on 10% Tris-HCl Ready Gels (Bio-Rad, Hercules, CA, USA). Extractions were
then transferred to an Immun-BlotTM polyvinylidene fluoride membrane (Bio-Rad) and hybridized
using the following primary antibodies: hCD44 (BD Pharmingen, San Jose, CA, USA, Catalog #
550988), hCD90 (BD Pharmingen, San Jose, CA, USA, Catalog # 555593), pCD44 (Abcam,
Cambridge, MA, USA, Catalog # ab19622), pCD117 (c-Kit; AbD Serotec, Raleigh, NC, USA,
Catalog # MCA2598), and #-actin (Abcam, Cambridge, MA, USA, Catalog # ab8226) for a
loading control. The secondary antibody to each primary was conjugated with horse radish
peroxidase (Bio-Rad) and an enhanced chemiluminescence (ECL) kit (Amersham,Little
Chalfont, Buckinghamshire, UK) was used for detection via exposure to x-ray film.
Karyotypic Analysis
At each passage analyzed (starting at passage 2), an additional 75 cm2 culture flask was
seeded with approximately 6,700 ASCs/cm2. Then 24 hours after plating, adherent cells were
incubated in a 0.05 "g/ml KaryoMAX® Colcemid® solution (Gibco) at 37°C for approximately 30
minutes. Cells were exposed to this low dosage of Colcemid® for only 30 minutes to reduce the
risk of the induction of aneuploidies. The synchronized cells were harvested by enzymatic
dissociation using trypsin and then resuspended and incubated in a 0.9% sodium citrate
hypotonic solution for 5 minutes in a 37°C waterbath. Swelled cells were then washed and
stored in fixative containing a 1:3 ratio of acetic acid:methanol at -20°C.
For slide preparation, the cells were washed in fresh, cold fixative and several drops
were placed on pre-cleaned glass slides (Gold Seal® Products, Portsmouth, NH, USA), which
were allowed to dry at room temperature for 10 minutes. The slides were then flooded with a
fixative solution of 1:1 acetic acid:methanol and allowed to dry again at room temperature for 10
minutes. The chromosomes were stained in 0.4% Accustain® Geimsa Stain (Sigma) for 15
minutes, rinsed with deionized water and air-dried at room temperature.
Metaphase spreads were observed using bright field microscopy under 100x oil
immersion. Spreads were selected only if chromosomes could be visibly distinguished from
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each other and were observably derived from a single cell. A digital image was captured for
each metaphase spread using the QCapture Pro imaging software (QImaging, Surrey, BC,
Canada). To avoid double counting, a digital mark was placed on each chromosome in each
picture using the Rincon™ (ImagingPlanet, Goleta, CA, USA) image analysis software. For
each cell line, 20 to 30 metaphase spreads were analyzed per passage. A total of 714
metaphase spreads were analyzed for this study.
Experimental Design
For flow cytometric analysis, a total of fourteen primary cell lines were established and
cultured until cells reached senescence. At each passage analyzed, cells were trypsinized and
re-seeded at 30 to 40% confluence to avoid possible contact inhibition and differentiation.
Passaged lines were cultured until 70 to 90% confluence was reached. A portion of cell lines
were analyzed for selected stem cell surface markers at early passages (PD 1-10) and late
passages (PD 11-34). For western blot analysis, total protein was extracted from three early PD
(<PD 3) cell lines. ECL-western blot analysis was performed on all three protein samples;
PVDF membranes were cut to separate and incubated accordingly for each stem cell surface
protein. The human protein extraction was derived from a PD 1 human ASC cell line and used
as a positive control for the human antibodies (CD44 and CD90) and to test for antibody crossreactivity for the porcine antibodies (CD44 and CD117). Representative exposed x-ray films are
presented.
For karyotype analysis, two ASC cultures were established from each of three primary
cell lines and were cultured under the exact same conditions. At each passage analyzed, one
culture was used to prepare metaphase spreads and the other was used to subculture the cell
line for continuous karyotype analysis at subsequent passages. Percent aneuploidies were
calculated at population doublings (PD) 1-10, PD 11-20 and PD 21-30.
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Statistical Analysis
In this study, Chi-square analysis was employed to karyotypic data in order to determine
statistical differences between cell lines (pASC 1, pASC 2 and pASC 3) and PD (PD 1-10, PD
11-20 and PD 21-30). For this test, a P < 0.05 was considered significant. Data were analyzed
using the SigmaStat Statistical Software Version 3.5 (Systat Software, Inc., San Jose, CA,
USA).
Results
Flow Cytometric Analysis of Stem Cell Surface Proteins
Flow cytometric analysis was performed on multiple pASC cell lines at early population
doublings (PD; PD 0-10) and at late PDs (PD 11-34) for the detection of the presence of various
stem cell surface markers. Results demonstrate that profiles are similar for some cell surface
markers and not similar for other markers on the human ASC surface as reported in the
literature (Gronthos et al., 2001; Katz et al., 2005; Lo Cicero et al., 2008). Analyses of porcine
ASCs at early PDs 0-10 demonstrated essentially no positive events for CD44 or the lectin
embryonic stem cell surface marker SSEA-4 (Table 4.1; Figure 4.1), whereas these proteins
were, in fact, found on the surface of human ASCs (Gronthos et al., 2001; Katz et al., 2005; Lo
Cicero et al., 2008). In this study, we also did not detect the presence of CD3, CD8, CD117 (cKit) or stem cell antigen-1 (Sca-1; Table 4.1; Figure 4.1). The lack of CD8 and CD117 was
consistent with the results for these proteins in human ASCs (Katz et al., 2005). At this time,
there is no literature to report the presence of CD3 or Sca-1 proteins on the human ASC
surface. However, the percentage of positive events for CD29 (4.74 + 2.37; range 0.1 – 10.5)
and CD90 (12.94 + 7.06; range 0 – 38.6) expression was found to be elevated and more
comparable to those values reported in the literature (Table 4.1; Figure 4.1). The mean percent
positive values generated for CD29 and CD90 are, however, lower than that reported for human
ASCs. It is important to note that the antibody used for CD90 was directed against a human
antigen and cross reactivity between the pig and the human species may not have occurred.
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Figure 4.1. Immunophenotypic analysis of porcine ASC surface proteins. Representative dot plots for CD3 (A), CD8 (B), CD29 (C),
CD44 (D), CD90 (E), CD117 (F), SSEA-4 (G) and Sca-1 (H). Dot plots represent porcine ASCs cultured at early PDs 0-10.
Quadrants were set according to fluorescence signals generated from propidium iodide and Alexa-Fluor® 488 and the percentage of
live cells positive for each stem cell antigen is depicted in the lower right corner.
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Table 4.1. Positive Events for Early Population Doublings 0-10
Surface
# Cell Lines
Mean % Positive +
Range (%)
Marker
Analyzed
SEM
pCD3
3
<1
0.1 – 0.2

‡

Human ASC %
Positive
NP

pCD8

3

0

0

0††

pCD29

5

70.58 + 13.25

33.9 – 92.8

98.1 + 1†

pCD44

6

6.98 + 1.73

4.4 – 10.2

60 + 15†

hCD90

5

86.14 + 5.66

69.5 – 96.5

25.96*

pCD117

5

1.00 + 0.66

0.1 – 3.6

0.2 + 0.4††

SSEA-4

3

<1

0.2 – 1.1

+**

mSca-1
3
<1
0.1 – 0.2
p = Porcine, h = Human, m = Mouse, NP = Not Published.
‡
All human ASCs cells analyzed were early passages.
†
Gronthos et al., J Cell Phys 2001; 189:54-63.
*Zuk et al., Mol Bio Cell 2002; 13:4279-4295.
††
Katz et al., Stem Cells 2005; 23:412-423.
**Lo Cicero et al., Cell Prolif 2008; 41:460-473.

NP
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Table 4.2. Positive Events for Late Population Doublings 11-34
Surface
# Cell Lines
Mean % Positive +
Range (%)
Marker
Analyzed
SEM
pCD3
3
<1
0 – 0.2

‡

Human ASC % Positive
NP

pCD8

3

<1

0 – 0.1

0††

pCD29

3

95.57 + 1.36

92.9 – 97.4

98.1 + 1†

pCD44

3

5.35

4.5, 6.2

60 + 15†

hCD90

3

88.77 + 8.21

72.3 – 97.4

25.96*

pCD117

3

<1

0.1 – 0.5

0.2 + 0.4††

SSEA-4

3

1.7

0.2, 3.2

+**

mSca-1

3

<1

0.2 – 0.3

NP

p = Porcine, h = Human, m = Mouse, NP = Not Published.
All human ASCs cells analyzed were early passages.
†
Gronthos et al., J Cell Phys 2001; 189:54-63.
*Zuk et al., Mol Bio Cell 2002; 13:4279-4295.
††
Katz et al., Stem Cells 2005; 23:412-423.
**Lo Cicero et al., Cell Prolif 2008; 41:460-473.

‡
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Analysis of porcine ASCs at late PDs 10-34 also demonstrated that CD3, CD8, CD44,
CD117, SSEA-4 and Sca-1 proteins tested were virtually non-existent on the surface of porcine
ASCs (Table 4.2; Figure 4.1). However, CD29 expression remained elevated in the later PDs
with a mean percent positive value of 7.80 + 0.78 and a range of 6.5 – 9.2 (Table 4.2; Figure
4.1). Additionally, the percentage of positive events for CD90 (7.77 + 3.83; range 0.3 – 13.0
remained elevated in the later passages. These values determined for CD29 and CD90 are
more consistent with the values reported for the human ASCs, although it is important to note
that the cells analyzed in these reports were early PDs and were not cultured as long as the
cells in this study (Tables 4.1 and 4.2). Gronthos et al. studied cells cultured through two
passages and cryopreserved (Gronthos et al., 2001), Katz et al. utilized human ASCs passage
2 or earlier (Katz et al., 2005) and Lo Cicero analyzed passage three cells (Lo Cicero et al.,
2008). Nevertheless, the values are a good reference and our results indicate that the
expression levels did not elevate in response to the duration in culture.
Western Blot Analysis of Stem Cell Surface Proteins
Immunoblot detection was paired with an ECL kit to confirm flow cytometric results of
select stem cell surface markers analyzed. For both the human and porcine protein extractions,
!-actin was utilized as a loading control and confirmed the presence of protein extraction in
each sample (Figure 4.2). As expected, antibodies used against the human CD44 and CD90
proteins revealed a positive expression in human ASCs as indicated by bands present at the
expected sizes (85 kDa and 25-35 kDa, respectively). However, the human antibodies did not
detect expression for CD44 or CD90 in porcine ASCs by Western blot analysis (Figure 4.2). In
response to this result we utilized a porcine antibody to CD44, but did not detect the protein in
either the porcine or the human protein extractions (Figure 4.2). The porcine antibody to CD117
also did not identify the protein in the porcine or human protein extractions (Figure 4.2). The
inability to detect any of the proteins analyzed by x-ray exposure verifies the findings derived by
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Figure 4.2. Western blot analysis of human and porcine ASCs for CD44, CD90 and CD117.
Human CD44 and CD90 antibodies detected the protein in the human protein extraction (H) but
not in the porcine protein extraction (P). Porcine CD44 and CD117 antibodies did not detect the
protein in either the human or the porcine protein extractions.
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flow cytometric analysis except for CD90. Again, we suspect that antibody cross reactivity did
not occur between the pig in the human especially for the CD90 antigen.
Chromosomal Stability of pASC Through In Vitro Culture
Metaphase spreads were observed and selected following the previously described
criteria. Digital images were captured for each metaphase spread and each chromosome was
documented using a digital marking system. A normal porcine metaphase spread consisted of
38 chromosomes (2n = 38) (Figure 4.3 A) and an aneuploid cell contained chromosome
numbers other than 38 (38 + X) (Figure 4.3 B). For each cell line, 20 to 30 metaphase spreads
were analyzed per passage. Table 3 illustrates a total of 714 metaphase spreads analyzed for
this study. Of 714 metaphases analyzed, 509 (71.3%) were aneuploid and only 205 (28.7%)
were normal diploid porcine cells (Table 4.3). Hypoploid cells represented 66% (336) of
aneuploid cells and the remaining 33.2% (169) (hyperploid and tetraploid combined) were
hyperploid (Table 4.3). There were 153 (45.5%) cells that contained 37 or 36 chromosomes,
141 (42.0%) cells with a range of 35 to 32 chromosomes and 42 (12.5%) contained less than 32
chromosomes (Table 4.3).
For each cell line, (pASC 1, pASC 2 and pASC 3) we found a remarkable percentage of
aneuploidies (43.7, 48.9 and 47.3, respectively, with a 46.6 + 1.5 average) present immediately
after the cultures were established (PD 1-10). Chi-square analysis indicates that the percents of
aneuploid cells during PD 1-10 were significantly lower than those for PD 11-20 and PD 21-30
(Table 4.4) (Figure 4.4). The statistical difference was observed individually within a cell line
and as an average of the three cell lines between PD groups (PD 1-10, PD 11-20 and PD 2130) (Table 4.4; Figure 4.4).
Discussion
Previously, we determined that porcine ASCs expressed the classic characteristics of
stem cells by demonstrating the ability to self-renew through ring cloning experiments and the
ability to differentiate along multiple tissue lineages (Williams et al., 2008). Those findings were
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Figure 4.3. Metaphase spreads of porcine ASCs. Normal diploid porcine metaphase spread
with 38 chromosomes (left). Aneuploid porcine metaphase spread with 52 chromosomes (right,
magnification 100X oil immersion).
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Table 4.3. Types of Aneuploidies in pASCs Derived By In Vitro Culture (PD 1-30)
Total metaphases analyzed
714
Diploid cells (%)

205 (28.7)

Aneuploid cells (%)

509 (71.3)

Hypoploid cells = 38 – X (%)

336 (66.0)

37 – 36 chromosomes (%)

153 (45.5)

35 – 32 chromosomes (%)

141 (42.0)

< 32 chromosomes (%)

42 (12.5)

Hyperploid cells = 38 + X (%)

169 (33.2)

Tetraploid cells = 76 chromosomes (%)

4 (0.8)
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Table 4.4. Chromosomal Stability of In Vitro Cultured pASC Population
Through PD 30
Aneuploid Cells (%)
Cell Line
N
PD 1 – 10
PD 11 – 20
PD 21 – 30
pASC 1
243
43.7a
87.1b
96.8b
a
b
pASC 2
220
48.9
82.1
100.0b
pASC 3
251
47.3a
91.7b
86.3b
a
b
Mean
714*
46.6 + 1.5
87.0 + 2.8
94.4 + 4.1b
n = number of metaphases analyzed per cell line.
*Total number of metaphases analyzed.
Standard error of the mean was calculated for the mean in each PD group.
Different letters within rows represent significant statistical differences
between PD derived by Chi-square analysis (P < 0.05).
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Figure 4.4. Chromosomal stability of porcine ASCs through in vitro culture. For pASC 1, pASC
2 and pASC 3 cells lines, the proportion of aneuploid cells was significantly higher in later PD
(PD 11-20 and PD 21-30) than the earlier PD 1-10. Letters indicate significant differences
between mean values of 46.6 + 1.5, 87.0 + 2.8 and 94.4 + 4.1 with a P < 0.05.
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consistent with the characteristics determined in human ASCs (Halvorsen et al., 2001a; Hauner
et al., 1989). Human and porcine adipose tissues offer an alternative stem cell source, can
beaccessed easily with little pain and are plentifully available. ASCs show much promise for
use in reconstructive tissue engineering and therapeutic cloning. The present study is the first
to describe the cell surface profile for stem cell associated surface markers comparing early and
late passages of undifferentiated porcine ASCs as well as to determine the chromosomal
stability through in vitro culture. The surface phenotype of porcine ASC is similar for some stem
cell antigens and different for others when compared to human ASC cell surface as reported in
the literature (Gronthos et al., 2001; Katz et al., 2005; Mitchell et al., 2006; Zuk et al., 2002).
Unlike reported values for human ASCs, porcine ASCs did not demonstrate positive
expression for CD44 or SSEA-4. The absence of CD44 was confirmed by western blot
analysis. However, our previous study did reveal positive gene expression of CD44 though
reverse transcriptase polymerase chain reaction (Williams et al., 2008). Neither SSEA-4, found
on bone marrow MSCs and human ASCs, nor Sca-1, also found on MSCs, was detected on the
surface of porcine ASCs at early or late PDs. Consistent with the literature, however, CD29 and
CD90 expression was detected in early and late PDs while CD8 and CD117 antigens were not
present at early or late PDs. Our study is by no means a comprehensive investigation for stem
cell markers potentially present on the surface of porcine ASCs. Bone marrow-derived MSCs
and human ASCs have been more fully characterized in the literature and many more of these
antigens need to be explored in porcine ASCs. Additional antigens for further investigation
include CD13, CD49, CD51, CD61, CD63, CD73, CD105, CD106, CD138, CD140, CD146 and
CD166 (Gronthos et al., 2001; Katz et al., 2005; Mitchell et al., 2006; Zuk et al., 2002). Cell
surface proteins were chosen in the current study based on their availability and their indication
of “stemness” in human ASC populations. At this time, the selection of antibodies commercially
available is an obstacle for thoroughly investigating these characteristics in the porcine animal
model. Human CD90 and mouse Sca-1 antibodies were used in flow cytometric analysis, while

82

human CD44 antibody (along with porcine CD44) was employed in the Western blot analysis.
Antibody cross reactivity between species most likely did not occur as results indicate in the
western blot analysis. However, all other antibodies were specific for porcine.
The inconsistency between porcine and human ASC surface may be due to several
factors effecting the in vitro culture environment. It has been proposed that the expression
pattern may not be reproducible because of cellular response to a hostile environment (Katz et
al., 2005). The exposure of cells to culture vessel plastic, the specific medium used, the
duration of culture (i.e. passage number, cell cycle length), the seeding density or whether the
cells have been cryopreserved prior to culture all could influence the phenotype of the cell as it
adapts to this environment (Katz et al., 2005; Planat-Benard et al., 2004; Rehman et al., 2004).
Another important factor is the tissue donor including the age of the donor and the physiological
location of tissue collection. Human ASCs are derived from processed liposuction aspirates
where in this study porcine ASCs were harvested from subcutaneous biopsies.
The age of the donor dictates the life expectancy of the cells in culture (Cristofalo et al.,
1998). This phenomenon is extremely important when selecting cells to be used as donor cells
in NT. The process of NT requires a donor cell with a normal diploid that has not yet reached
senescence. The establishment of an applicable genetically modified donor cell requires
multiple PDs, which increases the probability that the cells will acquire cytokinetic abnormalities
and chromosomal alterations. The use of an afflicted donor cell is most likely responsible for the
production of abnormal embryos that do not survive and may be the culprit of extremely low
success rates in NT.
Studies of chromosomal integrity through in vitro culture are quite limited at this time.
Giraldo et al. in 2006 characterized the proliferative capacity and the chromosomal stability of
bovine fetal fibroblasts. The level of aneuploid cells was highly elevated with a mean value of
47.9 + 5.5 immediately after the primary cultures were established (Giraldo et al., 2006). As the
cells progressed through culture the aneuploid levels dramatically increased (67.4 + 1.4 for
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middle PDs and 85.0 + 4.3 for late PDs (Giraldo et al., 2006). Our findings for porcine ASCs
were very similar. Porcine ASCs demonstrated an increased percentage of aneuploid cells
directly from the initiation of culture with a mean value of 46.6 + 1.5. The percentage of
aneuploid cells significantly increased for middle PDs (87.0 + 2.8) and late PDs (94.4 + 4.1).
We conclude that the assault to chromosomal stability clearly occurs after removing the cells
from their in vivo environment, which is supported by such elevated levels of aneuploidy directly
from the start in both bovine fetal fibroblasts and porcine ASCs. The suboptimal culture
conditions continue to corrode the genetic stability of the cells as they fight to survive in vitro
culture through middle and late PDs as indicated by the significant increases in aneuploidy.
NT efficiency may significantly increase with the implementation of a method to select
karyotypically normal diploid cells since approximately 50% of in vitro-cultured cells in early PDs
are aneuploid. However, the techniques available at this time for determining chromosomal
content are terminally destructive to the cell. Until new methodology can be discovered, it is
advantageous to choose donor cells at younger PDs. With this in mind, improving the methods
for generating transfected cells for NT at younger PDs would also likely increase the efficiency
of NT techniques.
The availability of an animal model for somatic stem cells will aid in tissue regeneration,
gene therapies and the development of other stem cell research techniques. The differences
found between porcine ASC and human ASC surface markers may be attributed to many
factors including the location of the fat depot as well as the age of the donor. Therefore care
should be taken when interpreting results from animal models of somatic stem cells. A
selection procedure for younger NT donor cells will minimize chromosomal defects and increase
reprogrammability necessary for healthy embryo production. Continued research will be
needed to identify a selection method as well as improve the manipulation of other cellular
mechanisms involved in the process of NT.
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CHAPTER V
EPIGENETIC MODIFICATIONS OF CULTURED PORCINE ADIPOSE TISSUE-DERIVED
STEM CELLS
Introduction
Currently, nuclear transfer results in relatively low success rates and investigators have
reported substantial problems with the welfare of the cloned animals. Developmental
abnormalities observed following nuclear transfer define Large Offspring Syndrome or LOS and
include low pregnancy rates, high percentages of loss during early and late pregnancy,
stillbirths, early postnatal deaths, short life-span, obesity and malformations. LOS may be
caused by several factors such as using an inappropriate donor cell and/or recipient oocyte, the
inability to properly synchronize the cell cycle phase of the donor nucleus and the recipient
cytoplasm and inadequate reprogramming of the donor genome. Also, the inappropriate
handling of oocytes, somatic cells and embryos during maturation with the subjection of these
cells to the various necessary manipulations and culture techniques could result in cellular
stresses leading to LOS.
A shift in research has focused on the epigenetic modifications of DNA and their role in
embryonic development. In the production of a normal developing embryo, the oocyte (arrested
at metaphase II) is united with a sperm and completes meiosis and extrudes the second polar
body. The embryo contains a subset of cells that remain totipotent (can support differentiation
into all cell types) for the first one to two cell divisions (Kono, 1997). The following cleavage
events undergo DNA modifications, which render them unable to form all tissue types and once
initiated it is believed that the series of events proceeds beyond the point of no return.
However, exposure of a donor cell’s chromatin to ooplasm as in nuclear transfer will redirect the
programming of the donor nucleus to mimic that of a zygotic nucleus as in normal fertilization
(Kikyo and Wolffe, 2000). The oocyte virtually erases the epigenetic modifications imposed on
the genome during differentiation and reinstates totipotency (Kikyo and Wolffe, 2000). The
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reprogramming of the donor cell nucleus is essential to initiate and complete embryonic
development.
Fusion with embryonic stem cells provides an alternative method for inducing nuclear
reprogramming of somatic nuclei. Factors within the embryonic stem cell, much like in the
unfertilized oocyte, render a resultant hybrid cell, which demonstrates pluripotent competence
by differentiation into multiple cell lineages and expression of tissue-specific genes (Cowan et
al., 2005; Tada et al., 2001). Several somatic cell types have been successfully reprogrammed
upon fusion with embryonic stem cells including thymocytes (Tada et al., 2001), human
fibroblasts (Cowan et al., 2005), and human myeloid precursor cells (Yu et al., 2006). Research
indicates that the nuclear compartment of the embryonic stem cell houses the reprogramming
capability because fusion of karyoplasts and not cytoplasts generate the reprogrammed hybrid
(Do and Scholer, 2004).
These reprogrammable epigenetics govern the regulation of repression of genes not
necessary in cell types at specific developmental stages while preserving the DNA sequence
(Wolffe and Matzke, 1999). Epigenetic modifications during the reprogramming process
following nuclear transfer include DNA methylation and posttranslational acetylation,
phosphorylation and methylation of histone N termini that function to modulate chromatin
structure, which ultimately regulates transcriptional activation or repression of specific genes.
Acetylatable lysine residues in the N termini of histone H3 (such as K9, K14, K18, and K23) and
H4 (such as K5, K8, K12, and K16) and methylatable lysine residues in H3 (such as K4, K9,
K27, K36, and K79) and H4 (K20) are only a few that have been identified (Kimura et al., 2004).
Histone acetyltransferases (HATs) are the enzymes responsible for the transfer of acetyl groups
to lysine residues and histone deacetylases (HDACs) dictate their removal. Acetylation
neutralizes the positive amino acid charge decreasing the affinity for DNA. The termini displace
from the nucleosome increasing accessibility of transcription factors, which leads to gene
expression (Grunstein, 1997). Alternatively, DNA methyltransferases (Dnmts) coordinate
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methyl group addition to DNA, which demarcates or “imprints” portions of DNA in order to
distinguish between silenced and expressed genes of parental alleles (Cezar, 2003).
H19, insulin-like growth factor II, and the insulin-like growth factor II receptor are
examples of genes that display alternative DNA methylation patterns based on the inheritance
of the allele either from the sperm or the oocyte (Kono, 1997). Generally, DNA methylation
blocks transcription factors from binding the methylated sequences and is associated with
transcriptional silencing and imprinting (Hiendleder et al., 2004b). The transcription repressor
protein, methyl CpG-binding protein-2 (MeCP2), binds methylated DNA which then as a
complex recruits HDACs (Jones et al., 1998; Nan et al., 1998). The removal of acetyl groups
from histone tails increases histone affinity for DNA further preventing transcription factor
accessibility (Cezar, 2003).
In nuclear transfer, genes normally expressed during embryogenesis are silent in
somatic donor cells and must be turned back on. Therefore, the DNA methylation patterns must
be reorganized to resemble that of undifferentiated nuclei (Rideout et al., 2001). LOS and other
phenotypic abnormalities may be a result of improper expression of imprinted genes as a result
of reorganized DNA methylation (Kono, 1997).
Regulators of development in undifferentiated cells are suggested to be silenced by the
presence of a bivalent domain modification pattern in which a large region of histone 3 lysine 27
trimethylation (H3K27me3) contains smaller regions of histone 3 lysine 4 trimethylation
(H3K4me3) (Bernstein et al., 2006). Important to the maintenance and pluripotency of stem
cells, Polycomb-group proteins catalyze the H3K27me3 modification and Trithorax group
proteins catalyze the H3K4me3 modification (Bernstein et al., 2006). The dual marks contain
both repressive (H3K27me3) and activating (H3K4me3) modifications, which work to silence
developmental genes in embryonic stem cells while simultaneously keeping them receptive to
activation. As the cell differentiates, the bivalent conformation resolves where H3K4me3
activating marks permit early-replicating gene expression and H3K27me3 repressing marks
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block late-replicating gene expression in cells committed to a specific lineage (Boyer et al.,
2006; Meshorer and Misteli, 2006).
Also of note, these developmental regulators contain highly conserved noncoding
elements, which contain a wealth of H3K27me3 and H3K4me3 harboring bivalent domains
(Bernstein et al., 2006). These regions house genes responsible for encoding several
transcription factors that function to maintain and regulate pluripotency and self-renewal in both
early embryos and embryonic stem cells (Bernstein et al., 2006). These factors include the
POU (Pit/Oct/Unc) domain-containing protein Oct-4 (also known as Pou5fl) (Nichols et al., 1998;
Niwa et al., 2000; Rosner et al., 1990; Scholer et al., 1990a; Scholer et al., 1990b), the high
mobility group (HMG)-box protein Sox-2 (Avilion et al., 2003) and the homeoprotein Nanog
(Chambers et al., 2003; Mitsui et al., 2003). These three transcription factors function through
very distinct pathways that are thought to converge to dictate early cell fate decisions (Boyer et
al., 2006). Recently, the conservation of these proteins among mammalian species has
become apparent and Oct-4, Sox-2 and Nanog are considered markers of cells that have
pluripotent capabilities. Also, their association with highly conserved non-coding elements
suggests a conserved role for the bivalent chromatin domains mentioned above (Bernstein et
al., 2006).
The initial epigenetic landscape of the DNA sequence determines the pluripotent
capabilities of the cell. Embryonic stem cells possess transcriptionally active chromatin that is
structured in an open configuration containing an abundance of acetylated lysine residues
(Boyer et al., 2006). However, as the cell commits to a differentiation pathway, acetylated
histone modifications decrease, heterochromatin formation ensues and pluripotential declines
(Meshorer and Misteli, 2006; Meshorer et al., 2006).
At this time, research has not identified epigenetic modifications in adult somatic MSCs
from porcine adipose tissue. Analysis of these cells may reveal global methylation and/or
acetylation patterns similar to their embryonic stem cell counterparts. Further characterization
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of porcine ASCs in this manner could assist the isolation and purification of a population of
MSCs from the easily obtainable tissue of adipose that can later be tested as donor cells in
nuclear transfer. Somatic cells used as donor cells in nuclear transfer typically produce more
blastocyst stage embryos compared to embryos derived from embryonic stem cells (Rideout et
al., 2001). Approximately 60% of embryonic stem cells are in S-phase when used as donor
cells (Rideout et al., 2001). S-phase embryonic stem cells are exposed to high levels of
maturation promoting factor, which induces premature nuclear envelope breakdown and
chromosome condensation. Cells likely undergo a second DNA replication cycle activating cell
checkpoint mechanisms ultimately leading to inappropriate ploidy and cell cycle arrest.
However, more embryonic stem cell nuclear transfer embryos develop to term than somatic cell
nuclear transfer embryos (Rideout et al., 2001). Although nuclear transfer clones produced
from either embryonic stem cells or somatic cells demonstrate similar phenotypic abnormalities,
term embryonic stem cell nuclear transfer clones indicate that utilization of a less differentiated
donor cell may be more acquiescent to appropriate reprogramming (Rideout et al., 2001).
Our overarching hypothesis is that low development rates observed following porcine
nuclear transfer are a result of incomplete reprogramming of the donor cell nucleus and that
somatic stem cells or those cells which demonstrate stem-like characteristics (i.e., ASCs) will be
reprogrammed more completely. New information concerning the nature of the epigenetic
landscape will aid the efficiency of isolation and purification of a population of MSCs from the
easily obtainable tissue of porcine adipose that can later be tested as donor cells in nuclear
transfer.
Materials and Methods
All reagents were purchased from Sigma Chemical Co. (St. Louis, MO, USA) unless
otherwise stated.
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Establishment of Primary Cultures and Cell Culture Maintenance
Primary cultures were established following procedures previously documented
(Williams et al., 2008). Briefly, 10 g subcutaneous fat was harvested from the dorsal abdominal
area in mature female cross-bred domestic pigs between the ages of 6 months to 1 year at a
local abattoir. The tissue was finely minced and washed with Dulbecco’s phosphate-buffered
saline (dPBS) containing 200 U/ml of penicillin and 200 "g/ml of streptomycin and 2.5 "g/ml of
Fungizone (Gibco). Each sample was homogenized with an equal volume of 0.1% collagenase
Type I (240 IU/ml; Gibco) in dPBS with 1% bovine serum albumin (BSA) in a shaker incubator
rotating at 200 rpm at 39°C for 2 h.
The cell suspension was filtered through a dual filter system comprised of two nylon net
filters (20 "m and 180 "m) (Millipore, Bedford, MA, USA). Cells were then stained with Hoechst
33342 (2 "g/ml) to determine the number of nucleated cells in the suspension. Cells were
plated at 6,700 cells/cm2 in 10 ml of expansion medium containing Dulbecco’s Modified Eagle
Medium (DMEM) (Hyclone, Logan, UT, USA) with high glucose supplemented with 10% fetal
bovine serum (FBS) (Hyclone), 100 U/ml of penicillin and 100 "g/ml of streptomycin and 2.5
"g/ml of Fungizone in a 150 cm2 culture flask and incubated at 39°C in 5% CO2.
Fresh medium was supplied every 3 to 4 days. When 70 to 90% confluence was
achieved, the porcine adipose-derived stem cells (pASCs) were harvested by trypsinization,
counted using a hemacytometer and re-seeded at an initial concentration of 6,700 cells/cm2.
Cells were passaged until replicative senescence was noted.
Differentiation of pASC Cultures
At 70 to 90% confluence (following passage 6), cells were passaged by trypsinization
and cultured for 21 days in culture medium previously demonstrated to induce differentiation
(Zuk et al., 2002; Gimble and Guilak, 2003). Culture media were changed every 3 to 4 days
throughout the study. For adipogenesis, cells were cultured on days 1 to 4 in differentiation
medium containing DMEM supplemented with 3% FBS, 100 U/ml of penicillin and 100 "g/ml of
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streptomycin, 2.5 "g/ml of Fungizone, 10 ng/ml of insulin, 10–9 M dexamethasone, 250 "M
isobutyl methylxanthine and 0.2 mM indomethacin. Culture medium beyond day 4 contained
DMEM with 3% FBS, 100 U/ml of penicillin and 100 "g/ml of streptomycin, 2.5 "g/ml of
Fungizone, 10 ng/ml of insulin and 10–9 M dexamethasone. For chondrogenesis, cells were
cultured for the duration of differentiation in medium containing DMEM with 10% FBS, 100 U/ml
of penicillin and 100 "g/ml of streptomycin, 2.5 "g/ml of Fungizone, 6.25 "g/ml of insulin, 10
ng/ml of transforming growth factor-! and 10–9 M dexamethasone. For osteogenesis, cells were
cultured in differentiation medium containing DMEM with 10% FBS, 100 U/ml of penicillin and
100 "g/ml of streptomycin, 2.5 "g/ml of Fungizone, 10 mM !-glycerophosphate, 50 ng/ml of
ascorbic acid and 10–9 M dexamethasone.
Histological staining techniques were used to determine differentiation. Nile Red, a stain,
which detects intracellular lipid accumulation, was used to determine adipocyte differentiation.
Safranin O was utilized to identify glycosaminoglycans in the extracellular matrix of
differentiated chondrocytes. After osteogenic induction, Alizarin Red S was employed to detect
mineralized calcium deposition.
Stem Cell Surface Immunolabeling for Methylated DNA and Acetylated Histone H3
Porcine ASCs were harvested by trypsinization, washed and resuspended in dPBS. The
protocol established by Habib et al. (1999) was used to fix and immunolabel cells. Briefly,
pASCs were permeated by 3 washes in a dPBS solution containing 1% BSA and 0.1% Tween20 (PBST-BSA). pASCs were then fixed in a 0.25% paraformaldehyde solution for 10 min at
37˚C and then stored in 90% cold methanol at -20˚C at least overnight. Following two washes
in PBST-BSA, cells were treated with 2N HCl for 30 minutes at 37˚C. A 0.1M boric acid buffer
(pH 8.5) was used to neutralize the fixative for 5 minutes at room temperature. pASCs were
washed 3 times in a dPBS solution containing 1% BSA and incubated in the last wash for 30
minutes at room temperature to block nonspecific binding sites. For methylated DNA, pASCs
were incubated first in dPBS with 5 "g/ml mouse anti-5-methylcytidine (AbDSerotec, Oxford,
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UK; Catalog # MCA2201) for 30 min at room temperature followed by incubation in dPBS with
20 "g/ml Alexa Flour® 488 goat anti-mouse IgG (H+L) (Carlsbad, CA, USA; Catalog # A11001)
for 30 minutes at room temperature. For acetylated histone H3, pASCs were incubated first in
dPBS with 10 "g/ml anti-acetyl-Histone H3 (rabbit polyclonal IgG) (Millipore, Temecula, CA;
Catalog # 06-599) for 30 minutes at room temperature followed by incubation in dPBS with 20
"g/ml Alexa Flour® 488 goat anti-rabbit IgG (H+L) (Carlsbad, CA, USA; Catalog # A11008) for
30 min at room temperature. pASCs were then counterstained in a 0.112% sodium citrate
solution containing 50 "g/ml propidium iodide and 10 "g/ml RNase for 30 min at room
temperature. pASCs were washed and resuspended in dPBS at a concentration of
approximately 1 x 106 pASCs/ml for flow cytometric analysis. A portion of cells was observed
under 100x magnification to verify antibody specificity for nuclear localization (Figure 5.3).
Flow Cytometric Analysis of Epigenetic Modifications
Samples were analyzed for relative levels of methylated DNA and acetylated histone H3
using the AccuriTM C6 Flow Cytometer® (Accuri Cytometers, Ann Arbor, MI, USA). At each
passage (1, 2, 3, 4, 5, 7 and 9) for every line analyzed (FPF 1, 2, 3 and 4, and pASC 1, 2, 3 and
4), at least 10,000 cumulative events were collected. Labeled cells were excited with a 488 nm
diode laser and a >670 nm band pass filter was used to detect PI levels (FL3-channel). The
DNA content derived from the PI levels was used to gate cells in G0/G1 phase (FL3-channel).
Total methylated DNA and acetylated histone H3 levels in G0/G1 cells were then detected in the
FL1-channel at 530/30 nm. Dot plots and histograms were derived using the Accuri CFlow
Plus® (Accuri Cytometers, Ann Arbor, MI, USA) software. Positive fluorescent events detected
in the FL1-channel were designated a mean value generated by the software and recorded as
arbitrary fluorescence units (AFU).
RNA Extraction and RT-PCR for Chromatin Remodeling Proteins
Total pASC and fetal porcine fibroblast (FPF) messenger RNA was isolated from
approximately 1 x 106 cells using the TRI-Reagent® RNA/DNA/Protein Isolation Reagent
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(Molecular Research Center, Inc., Cincinnati, OH) according to the manufacturer’s instructions.
Briefly, media was discarded from cultured pASCs and FPFs grown in a monolayer. The TRI
reagent was added to monolayers and allowed to incubate at room temperature for 5 minutes.
Cell lysates were passed several times through a pipette and transferred to 15 ml phase lock
tubes. The BCP reagent (1-bromo-3 chloropropane) was then added to the lysates, shaken
vigorously and incubated at room temperature for 1 hour. Lysates were centrifuged at 12,000 x
g for 15 minutes at 4°C to separate phases in which the upper transparent aqueous phase was
transferred to a clean 15 ml centrifuge tube. Isopropanol was added to the aqueous phase and
shaken to extract the RNA. Samples were stored at -20°C overnight and centrifuged at 12,000
x g for 20 minutes at 4°C the following day. The RNA pellet was then washed with 75% ethanol
made with DEPC treated water, air dried and then resuspended in DEPC treated water.
Extracted total RNA was stored in -20°C for approximately 3 months and then reverse
transcribed using the iScript® cDNA Synthesis Kit (Bio-Rad Laboratories, Inc., Hercules, CA,
USA) according to the manufacturer’s instructions. The iScript® reverse transcription (RT)
reaction volume was carried out in 20 µl total and contained 4 µl of iScript® reaction mix, 15 µl of
mRNA and 1 µl reverse transcriptase. Reaction mixes were concocted for each sample and a
no reverse transcriptase negative control. Negative control reactions were analyzed by gel
electrophoresis to verify the absence of contaminating genomic DNA (data not shown).
Quantitative Real Time PCR for Chromatin Remodeling Proteins
PCR primers were designed using the Beacon Designer 4.0 (PREMIER Biosoft
International, Palo Alto, CA, USA) software for the amplification of DNA methyltransferase 1
(Dnmt1), Dnmt3a, histone deacetylase 1 (HDAC1), methyl CpG-binding protein-2 (MeCP2) and
the reference gene polyadenylate polymerase (Poly A) from both porcine and bovine gene
sequences (Table 5.1). cDNA was amplified in a reaction mix with a total volume of 25 µl
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Table 5.1. Oligonucleotide PCR primers for real time quantitative PCR
Accession
Gene
Forward/Reverse
Primer
Number
Gene Expression Analysis of Chromatin Remodeling Proteins
pDnmt1
F
NM_001032355
CAGACAAGTGGTGAGGAC
R
pDnmt3a

F
F

DQ785811

F

AK230658

F

XM_588477

CATCTGGCTTCTGTTACG
CCGCTGGGAAGTATGATGTG

AK233143

GACTGACTGCCTGCTTACAC

R

F

NC_010449

F

214

GGTGTCCGATTGATTCCTC

200

GCCCAGCCTATTAGATTCC
EF522119

R
pNANOG Distal*

137

CCAGGTCCGAGGATCAAC

R
pNANOG Proximal*

191

TTTCTCGTATCCACTCTTTGACC

Chromatin Immunoprecipitation Analysis of Pluripotent Transcription Factors
pOCT4 Proximal
F
NC_010449
CAGAGGTCAAGGCTAGTG
F

139

GGGAGATTTGGGCTTCTTAGG

R

pOCT4 Distal

119

ACTCGGTCTGTGGTATAG

R
pPolyA

CCCGAAAGAGCACAACTG
GCACATTCCTCCGATGAAG

R
bMeCP2

186

TGTGAAATGAGATGTGATGG

R
pHDAC1

Amplicon
length (bp)

AATTCGCAAGGGTGTGTGTG

128

CAGGAGCTAACCACCCCAAT
EF522119

AGCTCATGGCAACGCTAGAT

115

R
TGACAGGAGTTTCCATCGTG
p = porcine; b = bovine; Dnmt = DNA methyltransferase; HDAC = histone deacetylase; MeCP = methyl CpG-binding
protein; PolyA = polyadenylate polymerase.
*Miyamoto et al., (2009).
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containing 12.5 µl iQTMSYBR Green Supermix (Bio-Rad Laboratories, Inc., Hercules, CA, USA),
2 µl cDNA, 8.5 µl nuclease-free water and 1 µl each of sense and antisense primers (20 pmol)
for each gene. Reaction mixes were concocted for each sample, a calibrator (derived from
porcine muscle tissue) and a no reverse transcriptase negative control. Quantitative real time
PCR (qPCR) was performed for all genes including the reference gene Poly A in the MyiQ
Reverse Transcription PCR Detection System (Bio-Rad Laboratories, Inc., Hercules, CA, USA)
using the program consisting of a denaturing cycle of 3 minutes at 95°C, 40 cycles of PCR (10
seconds at 95°C, 45 seconds at 55°C and 1 minute at 95°C), a melting curve for 1 minute at
95°C followed by 1 minute at 55°C, a step cycle starting at 55°C for 10 seconds with a
0.5°C/second transition rate, and a constant cooling cycle held at 4°C.
Livak and Schmittgen describe the comparative quantification cycle (C q) method used to
analyze qPCR data (Livak and Schmittgen, 2001). The data is reported as an n-fold change in
gene expression relative to the calibrator. The Cq of the reference gene Poly A was used to
normalize the target gene Cq in each sample. The !Cq for the transcription of each gene was
then calibrated against cells from porcine muscle tissue. The mean fold change in expression
of the target gene relative to the calibrator was calculated by 2-!!Cq and presented as fold
change in target gene expression.
All primers were validated for annealing temperature by performing an annealing
temperature gradient and subsequent analysis by gel electrophoresis (data not shown). Also,
primers were validated for the amplification of a single product in a quantitative manner,
efficiency level, correlation coefficient and melting curves of cDNA at five different dilutions
using qPCR (Figure 5.1). All target genes analyzed generated efficiencies between 95 to 113%
and correlation coefficients between 0.99 to 1.00.

98

A.

B.

C.

Figure 5.1 Primer validation. Representative melt curve (A), threshold cycle (Ct) values (B) and
standard curve (C) derived from a 1:10 template dilution series for the validation of forward and
reverse primers.
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Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were carried out according to the protocol
described by Dahl and Collas (Dahl and Collas, 2008) with a few modifications. Cells were
harvested by trypsinization as per standard protocol described above. Cells were counted using
a hemacytometer and approximately 2.5 x 106 cells were allocated to the ChIP assay. The use
of sodium butyrate in all solutions and buffers throughout the protocol was eliminated on the
basis that the epigenetic modification under investigation was not histone acetylation. Cells
were resuspended in 500 µl PBS. DNA-protein crosslinking was performed by
paraformaldehyde (1% v/v), vortexed gently and incubated at room temperature for 8 minutes.
The reaction was terminated with the addition of glycine (125 mM final concentration) and
incubated at room temperature for 5 minutes.
Sonication of chromatin was performed on a Branson Sonifier 250 Duty cycle 40% Level
4 for 10 times 20 pulses on ice with a 1 minute pause in between each set of 20 pulses.
Preparation of antibody-bead complexes was performed by incubating 11 !l well-suspended
protein A bead stock from Millipore MagnaChIP kit (Millipore, Billerica, MA, USA, Catalog
#MAGNA001) with 2.4 !g of antibody at 4°C for 2 hours at 40 rpm in a hybridization oven.
Chromatin was immunoprecipitated by incubating 100 !l diluted chromatin with the antibodybead complexes at 4°C overnight at 40 rpm in a hybridization oven. The DNA was eluted per
Dahl and Collas protocol and isolated using the spin filter columns provided in the Millipore
MagnaChIP kit following the manufacturer’s instructions.
PCR primers were designed using the Beacon Designer 4.0 (PREMIER Biosoft
International, Palo Alto, CA, USA) software for the amplification of a proximal and distal region
from the initiation of transcription within the promoter regions of both Oct-4 and Nanog (Table
5.1). cDNA was amplified in a reaction mix with a total volume of 25 µl containing 12.5 µl
iQTMSYBR Green Supermix (Bio-Rad Laboratories, Inc., Hercules, CA, USA), 2 µl cDNA, 8.5 µl
nuclease-free water and 1 µl each of sense and antisense primers (20 pmol) for each gene.
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Reaction mixes were concocted for each sample, a calibrator (derived from porcine muscle
tissue) and a no reverse transcriptase negative control. Quantitative real time PCR (qPCR) was
performed for all genes including the reference gene Poly A in the MyiQ Reverse Transcription
PCR Detection System (Bio-Rad Laboratories, Inc., Hercules, CA, USA) using the program
consisting of a denaturing cycle of 3 minutes at 95°C, 40 cycles of PCR (10 seconds at 95°C,
45 seconds at 55°C and 1 minute at 95°C), a melting curve for 1 minute at 95°C followed by 1
minute at 55°C, a step cycle starting at 55°C for 10 seconds with a 0.5°C/second transition rate,
and a constant cooling cycle held at 4°C.
We present the data as fold enrichment of precipitated DNA associated with either
H3K4me3 or H3K27me3 relative to a 1/100 dilution of input chromatin representing the
percentage of precipitate material relative to the amount in the input sample.
Experimental Design
Four cell lines each were established for porcine ASCs and porcine FPFs. Cells were
cultured until senescence was reached. At each passage analyzed, cells were trypsinized and
re-seeded at 30 to 40% confluence to avoid possible contact inhibition and differentiation.
Passaged lines were cultured until 70 to 90% confluence was reached. Following passage 6, a
portion of pASC cell lines were cultured under differentiation conditions to assess the stem cell
characteristics following that duration through in vitro culture. Relative levels of methylated DNA
and acetylated histone H3 as well as levels of chromatin remodeling protein expression were
analyzed for both porcine ASCs and porcine FPFs at each passage. These data are reported
for each passage analyzed, however, the population doublings at each passage for each
respective cell type is different based on their growth characteristics (PD 3, 5, 7, 10, 12 and 16
respectively for FPFs and PD 1, 3, 5, 7, 8, 10 and 11, respectively, for pASCs).
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Figure 5.2. Porcine fibroblasts and pASCs stained with anti-5-methylcytidine and anti-acetylhistone H3. pASCs stained with anti-acetyl-histone H3 (A and E), counterstained with PI (B and
F), anti-5-methylcytidine (C and G) and counterstained with PI (D and H). FPFs stained with
anti-acetyl-histone H3 (I), counterstained with PI (J), anti-5-methylcytidine (K) and
counterstained with PI (L).
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Statistical Analysis
In this study, chi-square analysis was employed to karyotypic data in order to determine
statistical differences between cell lines (pASC 1, pASC 2 and pASC 3) and PD (PD 1-10, PD
11-20 and PD 21-30). For this test, a P < 0.05 was considered significant. Data were analyzed
using the SigmaStat Statistical Software Version 3.5 (Systat Software, Inc., San Jose, CA,
USA). For DNA methylation and histone acetylation, student’s t-test was used to determine
statistical differences between cell types using a P value of < 0.05. Also, Tukey’s test was used
to determine statistical differences between passages using a P value of < 0.05. For chromatin
remodeling protein gene expression data, the Proc Mixed with repeated measures procedure
was used in SAS statistical software to determine statistical differences between cell type and
passages.
Results
Differentiation of pASCs
Following passage 6, a portion of pASCs was cultured in differentiation conditions for
adipogenesis, chondrogenesis and osteogenesis. All four pASC cell lines successfully
differentiated under adipogenic, chondrogenic and osteogenic conditions (data not shown).
Cells cultured under adipogenic conditions stained positive for intracellular lipids. Chondrogenic
induction generated cells that stained positive for the presence of glycosaminoglycans. Lastly,
osteogenic differentiation was detected by the presence of calcium deposition in cultured cells.
Antibody Specificity for Methylated DNA and Acetylated Histone H3
Epifluorescence microscopy reveals the specificity of high intensity staining for antiacetyl-histone H3 and anti-5-methylcytidine to the nuclear compartment for pASCs (Figure 5.2 A
and C, respectively). Counterstaining with PI confirmed the site of the fluorescent staining by
corresponding to DNA detected within the nucleus (Figure 5.2 B and D). A degree of
cytoplasmic fluorescence can be observed in both pASCs (Figure 5.2 A, C, E and G) and FPFs
(Figure 5.2 I and K), which may contribute to background fluorescence.
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Table 5.2. Levels of Methylated DNA in FFs and ASCs through in vitro culture
Methylated DNA (AFU) + SEM
Cell Line
P1
P2
P3
P4
P5
FPF 1
3990
2700
3106
2480
3264

P7
2744

FPF 2

6510

5782

3984

5214

5993

2972

FPF 3

6691

4724

3691

3350

3031

2946

FPF 4

7337

4360

4213

5100

5515

3241

Mean
pASC 1

6132
+ 736a,1
8856

4391
+ 639a,1,2
1836

3749
+ 239a,1,2
1110

4036
+ 671a,1,2
1001

4451
+ 760a,1,2
1834

2976
+ 102a,2
1965

6187

pASC 2

5236

1864

1034

1044

1599

2506

9336

pASC 3

8941

1346

1692

1422

2069

1961

4003

pASC 4

4901

2210

1342

1152

1675

1551
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Mean

6984
1814
1294
1155
1794
+ 1108a,1
+178b,1,2
+ 148b,2
+ 94b,2
+ 104b,1,2
AFU, arbitrary fluorescence units; SEM, standard error of the mean.
Different letters (a and b) within columns indicate significant difference between cell types.
Different numbers (1 and 2) within rows indicate significant difference between passages.
Student’s t-test was used to determine statistical differences between cell types (P < 0.05).
Tukey’s test was used to determine statistical differences between passages (P < 0.05).
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1996
+ 196b,1,2

P9

4907
+ 19401,2

Table 5.3. Levels of Acetylated Histone H3 in FFs and ASCs through in vitro culture
Acetylated Histone H3 (AFU) + SEM
Cell Line
P1
P2
P3
P4
P5
FPF 1
7392
7809
8644
3369
4269

P7
3261

P9

FPF 2

7597

9232

7384

4142

4646

3955

FPF 3

8654

6654

7108

1372

4526

2931

FPF 4

9029

6489

6330

3419

4039

3099

Mean
pASC 1

8168
+ 399a,1
17145

7546
+ 634a,1
11654

7366
+ 481a,1
4321

3076
+ 595a,2
3173

4370
+ 136a,2
4516

3312
+ 225a,2
3124

12090

pASC 2

10248

8997

5571

3063

3668

3061

13725

pASC 3

9811

7150

5377

2793

3558

3284

5883

pASC 4

8126

7536

5170

2621

3270

2108

5017

2894
+ 266a,2,3

9179
+ 21861,2,3

Mean

11333
8834
5109
2913
3753
+ 1991a,1,2
+1020a,1,2
+ 275b,1,2,3
+ 126a,3
+ 268a,1,2,3
AFU, arbitrary fluorescence units; SEM, standard error of the mean.
Different letters (a and b) within columns indicate significant difference between cell types.
Different numbers (1, 2 and 3) within rows indicate significant difference between passages.
Student’s t-test was used to determine statistical differences between cell types (P < 0.05).
Tukey’s test was used to determine statistical differences between passages (P < 0.05).
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Figure 5.3. Global levels of methylated DNA and acetylated histone H3 in FPFs and pASCs at different passages. Cells gated in
G0/G1 cell cycle stage based on PI counterstaining were designated a software-generated mean value. Each value was graphed for
each of four cell lines and analyzed for FPF DNA methylation (A), FPF histone H3 acetylation (B), pASC DNA methylation (C) and
pASC histone H3 acetylation (D).
106

Levels of Methylated DNA and Acetylated Histones in Porcine ASCs
Methylated DNA levels significantly decreased within the first passage for fibroblast cell
lines FPF 1, 2, 3 and 4 gated in G0/G1 cell cycle stage (Table 5.2; Figure 5.3 A). However, the
four lines appeared to diverge after passage 3 with methylated DNA levels remaining low for cell
lines FPF 1 and 3 and increasing for cell lines FPF 2 and 4 before a decrease to lower levels at
passage 7 (Figure 5.3 A). Relative levels of DNA methylation for pASCs also decreased
significantly between passage 1 and passage 3 and remained low through culture (Table 5.2;
Figure 5.3 C). As an average, pASC methylation levels were significantly lower than FPF levels
from passage 2 through passage 7 (Table 5.2).
Levels of acetylated histone H3 for cells gated in G0/G1 cell cycle stage for FPF cell
lines did not demonstrate a similar pattern between all four lines (FPF 1, 2, 3 and 4) through
culture but all together did show a significant decrease in mean AFUs after passage 3 (Table
5.3; Figure 5.3 B). pASCs were hyperacetylated at passages 1 through 3 when mean relative
levels significantly dropped at passage 4 (Table 5.2; Figure 5.3 D). When compared to FPFs,
mean levels of acetylated histone H3 were significantly lower for pASCs only at passage 3,
where as at all other passages analyzed the means were similar.
Analysis of Chromatin Remodeling Proteins Transcript Levels
mRNA levels for chromatin remodeling proteins Dnmt1, Dnmt3a, HDAC1 and MeCP2
were analyzed through RT-PCR. A mean fold change in gene expression relative to the
calibrator and normalized with Poly A was determined for all four genes in FPFs and pASCs
across passages 1, 2, 3, 4, 5, 7 and 9. Dnmt1 expression in pASCs increases through passage
3 and then tapers off during passage 3 through passage 9 (Table 5.4; Figure 5.4 A). FPF
expression levels of Dnmt1 do not appear to follow any specific pattern through culture. The
nature of passage 1 Dnmt1 expression level data is difficult to interpret and from passage 2 on
the levels oscillate up and down (Table 5.4; Figure 5.4 A). However, when comparing the pASC
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Dnmt1 expression pattern through culture to that of FPF, the levels are generally lower (Table
5.4; Figure 5.4 A).
Dnmt3a expression in pASCs follows a similar pattern to the expression of Dnmt1.
Through passage 3, Dnmt3a expression levels increase and then begin to decrease after
passage 3 through passage 9 (Table 5.5; Figure 5.4 B). Again, FPF expression levels of
Dnmt3a, similar to Dnmt1, do not follow a noted trend through culture (Table 5.5; Figure 5.4 B).
The Dnmt3a pattern of the FPFs is less consistent than the pASC pattern and again the pASC
levels are relatively lower than FPF levels (Table 5.5; Figure 5.4B). Also, for both cell types the
expression level for Dnmt3a as a whole is lower than that of Dnmt1.
The transcript levels for HDAC1 remained generally low throughout culture for both
pASCs and FPFs with the exception of passage 1 and 9 for FPFs (Table 5.6; Figure 5.4 C).
MeCP2 expression levels in pASCs, as expected, follow a similar trend through in vitro culture
as Dnmt1 and Dnmt3a. Transcripts levels increase through passage 3 and are followed by
subsequent decrease through passage 9 (Table 5.7; Figure 5.4 D). The abundance of MeCP2,
as a whole, is more comparable to that of Dnmt1 hovering around a 1-fold change relative to the
calibrator, whereas Dnmt3a levels are all under a 0.5-fold change (Tables 5.4, 5.5, 5.7; Figure
5.4). FPF expression levels of MeCP2 again are less consistent and do not follow any sort of
trend through culture (Table 5.7; Figure 5.4 D). pASC expression levels of MeCP2 are lower
when compared to the expression levels in FPF (Table 5.7; Figure 5.4 D).
Chromatin Immunoprecipitation of H3K4me3 and H3K27me3 Promoter Regions
Bivalent domains within the promoter regions work to silence developmentally important
transcription factors while simultaneously keeping them poised for activation. We analyzed
pASCs for the presence of the repressive H3K27me3 epigenetic modification and the activating
H3K4me3 epigenetic modification within the promoter region of Oct-4 and Nanog. Preliminary
evidence suggests that pASCs do, in fact, possess this bivalent chromatin structure in the
proximal promoter region of Oct-4 with a value of 27.97 + 13.56 for H3K4me3, as derived as a
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Table 5.4. Average Relative Transcript Levels of DNA methyltransferase 1 in FPFs and pASCs through In Vitro Culture
Fold Change in Dnmt1 Expression + SEM
Cell Line
P1
P2
P3
P4
P5
P7
P9
FPF 1
39.79
0.30
1.83
1.03
1.76
3.02
0.80
+ 31.80
+ 0.05
+ 0.24
+ 0.13
+ 0.35
+ 0.28
+ 0.08
FPF 2
0.66
0.18
1.93
1.30
2.63
1.26
0.00
+ 0.45
+ 0.02
+ 0.58
+ 0.37
+ 0.90
+ 0.35
+ 0.00
FPF 3
16.17
0.20
4.08
0.87
1.22
1.30
0.70
+ 11.46
+ 0.03
+ 1.39
+ 0.11
+ 0.09
+ 0.27
+ 0.08
FPF 4
0.41
0.12
1.07
1.12
1.08
1.17
0.57
+ 0.07
+ 0.01
+ 0.13
+ 0.12
+ 0.03
+ 0.04
+ 0.07
Mean
14.26
0.20
2.23
1.08
1.67
1.69
0.52
+ 9.281,a
+ 0.042,a
+ 0.652,a
+ 0.092,a
+ 0.352,a
+ 0.452,a
+ 0.182
pASC 1
0.34
0.23
2.85
0.46
0.33
0.36
0.28
+ 0.05
+ 0.03
+ 0.38
+ 0.03
+ 0.04
+ 0.03
+ 0.01
pASC 2
0.39
0.30
1.42
0.69
0.65
0.72
0.32
+ 0.05
+ 0.03
+ 0.22
+ 0.05
+ 0.09
+ 0.04
+ 0.01
pASC 3
0.39
0.56
0.33
0.84
0.91
0.43
0.23
+ 0.06
+ 0.07
+ 0.04
+ 0.06
+ 0.15
+ 0.05
+ 0.01
pASC 4
0.20
0.36
1.87
0.52
0.37
0.36
0.24
+ 0.03
+ 0.02
+ 0.41
+ 0.52
+ 0.04
+ 0.05
+ 0.04
Mean
0.33
0.36
1.62
0.63
0.57
0.47
0.27
1,a
1,a
1,a
1,b
1,b
1,b
+ 0.04
+ 0.07
+ 0.52
+ 0.09
+ 0.14
+ 0.09
+ 0.021
SEM, standard error of the mean.
Different letters (a and b) within columns indicate significant difference between cell types.
Different numbers (1 and 2) within rows indicate significant difference between passages.
ANOVA with repeated measures utilizing the Proc Mixed Procedure was used to determine statistical differences (P < 0.05).
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Table 5.5. Average Relative Transcript Levels of DNA methyltransferase 3a in FPFs and pASCs through In Vitro Culture
Fold Change in Dnmt3a Expression + SEM
Cell Line
P1
P2
P3
P4
P5
P7
P9
FPF 1
2.50
0.17
0.32
0.25
0.31
1.73
0.07
+ 2.15
+ 0.06
+ 0.03
+ 0.08
+ 0.15
+ 0.58
+ 0.01
FPF 2
0.03
0.08
0.25
0.29
0.30
0.33
0.00
+ 0.01
+ 0.03
+ 0.04
+ 0.02
+ 0.02
+ 0.10
+ 0.00
FPF 3
0.66
0.19
0.47
0.16
0.34
0.19
0.70
+ 0.62
+ 0.09
+ 0.07
+ 0.06
+ 0.01
+ 0.05
+ 0.05
FPF 4
0.27
0.12
0.12
0.15
0.30
0.17
0.69
+ 0.01
+ 0.08
+ 0.01
+ 0.03
+ 0.02
+ 0.03
+ 0.02
Mean
0.86
0.14
0.29
0.21
0.31
0.60
0.36
1,a
2,a
2,a
2,a
2,a
1,a
+ 0.56
+ 0.03
+ 0.07
+ 0.03
+ 0.01
+ 0.38
+ 0.191,a
pASC 1
0.09
0.04
0.54
0.03
0.02
0.01
0.04
+ 0.02
+ 0.02
+ 0.37
+ 0.03
+ 0.01
+ 0.00
+ 0.02
pASC 2
0.07
0.08
0.21
0.07
0.08
0.14
0.07
+ 0.01
+ 0.01
+ 0.04
+ 0.01
+ 0.01
+ 0.02
+ 0.02
pASC 3
0.07
0.14
0.11
0.20
0.12
0.06
0.04
+ 0.02
+ 0.03
+ 0.01
+ 0.02
+ 0.02
+ 0.02
+ 0.01
pASC 4
0.04
0.04
0.41
0.11
0.06
0.05
0.05
+ 0.01
+ 0.02
+ 0.41
+ 0.03
+ 0.01
+ 0.01
+ 0.01
Mean
0.07
0.07
0.32
0.10
0.07
0.06
0.05
+ 0.011,a
+ 0.021,a
+ 0.101,a
+ 0.041,a
+ 0.021,b
+ 0.031,a
+ 0.011,a
SEM, standard error of the mean.
Different letters (a and b) within columns indicate significant difference between cell types.
Different numbers (1 and 2) within rows indicate significant difference between passages.
ANOVA with repeated measures utilizing the Proc Mixed Procedure was used to determine statistical differences (P < 0.05).
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Table 5.6. Average Relative Transcript Levels of Histone Deacetylase 1 in FPFs and pASCs through In Vitro Culture
Fold Change in HDAC1 Expression + SEM
Cell Line
P1
P2
P3
P4
P5
P7
P9
FPF 1
13.93
0.12
0.28
0.19
0.26
0.54
0.11
+ 13.15
+ 0.01
+ 0.04
+ 0.03
+ 0.05
+ 0.05
+ 0.00
FPF 2
0.02
0.15
0.35
0.23
0.52
0.24
1.44
+ 0.02
+ 0.03
+ 0.05
+ 0.05
+ 0.19
+ 0.06
+ 1.18
FPF 3
0.14
0.13
1.07
0.17
0.25
0.23
0.78
+ 0.14
+ 0.03
+ 0.37
+ 0.01
+ 0.01
+ 0.03
+ 0.08
FPF 4
0.12
0.06
0.20
0.26
0.18
0.25
0.85
+ 0.02
+ 0.00
+ 0.01
+ 0.02
+ 0.01
+ 0.02
+ 0.09
Mean
3.55
0.11
0.48
0.21
0.30
0.32
0.80
1,a
2,a
2,a
2,a
2,a
2,a
+ 3.46
+ 0.02
+ 0.20
+ 0.02
+ 0.07
+ 0.08
+ 0.272,a
pASC 1
0.16
0.12
0.53
0.15
0.08
0.13
0.13
+ 0.02
+ 0.01
+ 0.09
+ 0.01
+ 0.01
+ 0.01
+ 0.00
pASC 2
0.18
0.13
0.35
0.17
0.11
0.35
0.14
+ 0.03
+ 0.01
+ 0.07
+ 0.01
+ 0.01
+ 0.02
+ 0.01
pASC 3
0.19
0.21
0.14
0.23
0.16
0.13
0.11
+ 0.01
+ 0.01
+ 0.01
+ 0.01
+ 0.02
+ 0.01
+ 0.00
pASC 4
0.11
0.32
0.27
0.14
0.10
0.14
0.08
+ 0.01
+ 0.01
+ 0.11
+ 0.03
+ 0.01
+ 0.02
+ 0.01
Mean
0.16
0.20
0.32
0.17
0.11
0.19
0.12
+ 0.021,a
+ 0.041,a
+ 0.081,a
+ 0.021,a
+ 0.021,b
+ 0.051,a
+ 0.011,b
SEM, standard error of the mean.
Different letters (a and b) within columns indicate significant difference between cell types.
Different numbers (1 and 2) within rows indicate significant difference between passages.
ANOVA with repeated measures utilizing the Proc Mixed Procedure was used to determine statistical differences (P < 0.05).
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Table 5.7. Average Relative Transcript Levels of Methyl CpG-Binding Protein-2 in FPFs and pASCs through In Vitro Culture
Fold Change in MeCP2 Expression + SEM
Cell
Line
P1
P2
P3
P4
P5
P7
P9
FPF 1
68.95
0.75
1.89
1.28
2.08
8.03
0.98
+ 33.65
+ 0.12
+ 0.15
+ 0.07
+ 0.20
+ 1.73
+ 0.08
FPF 2
2.32
0.38
2.30
1.43
2.41
3.58
260.66
+ 0.75
+ 0.05
+ 0.32
+ 0.30
+ 0.87
+ 1.00
+ 169.19
FPF 3
283.70
0.46
5.90
1.11
1.16
2.39
4.29
+ 279.83
+ 0.08
+ 2.03
+ 0.11
+ 0.08
+ 0.13
+ 0.48
FPF 4
0.33
0.15
1.12
1.24
1.02
2.11
7.02
+ 0.05
+ 0.01
+ 0.11
+ 0.09
+ 0.13
+ 0.15
+ 0.37
Mean
88.83
0.44
2.80
1.26
1.67
4.03
68.24
+ 66.891,a
+ 0.122,a
+ 1.062,a
+ 0.072,a
+ 0.342,a
+ 1.372,a
+ 64.151,a
pASC 1
0.48
0.57
3.55
0.53
0.25
0.36
0.54
+ 0.08
+ 0.04
+ 0.69
+ 0.09
+ 0.02
+ 0.01
+ 0.08
pASC 2
0.46
0.50
1.58
0.82
0.40
0.96
0.32
+ 0.06
+ 0.03
+ 0.30
+ 0.03
+ 0.01
+ 0.32
+ 0.02
pASC 3
0.46
0.68
0.35
0.95
0.50
0.29
0.24
+ 0.12
+ 0.05
+ 0.01
+ 0.11
+ 0.07
+ 0.03
+ 0.03
pASC 4
0.30
0.62
1.27
0.86
0.29
0.33
0.27
+ 0.10
+ 0.05
+ 0.84
+ 0.21
+ 0.04
+ 0.07
+ 0.02
Mean
0.43
0.59
1.69
0.79
0.36
0.49
0.34
1,a
1,a
1,a
1,b
1,b
1,a
+ 0.04
+ 0.04
+ 0.67
+ 0.09
+ 0.06
+ 0.16
+ 0.071,a
SEM, standard error of the mean.
Different letters (a and b) within columns indicate significant difference between cell types.
Different numbers (1 and 2) within rows indicate significant difference between passages.
ANOVA with repeated measures utilizing the Proc Mixed Procedure was used to determine statistical differences (P < 0.05).
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Figure 5.4. Histograms of the mean transcript levels in FPFs and pASCs for DNA methyltransferase-1 (Dnmt1), DNA
methyltransferase-3a (Dnmt3a), histone deacetylase-1 (HDAC1) and methyl CpG binding protein-2 (MeCP2). Means are reported as
a fold change in expression of each gene relative to a calibrator from porcine muscle tissue. Relative differences are depicted for
both FPFs and pASCs for expression of Dnmt1 (A), Dnmt3a (B), HDAC1 (C) and MeCP2 (D). Bars are representative of the
standard error of the mean.
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Table 5.8 Chromatin Immunoprecipitation for Bivalent Domain
Epigenetic Modifications
Percent + SEM
Gene Promoter
Lysine 4
Lysine 27
pOCT4 Proximal
27.97 + 13.56
31.81 + 6.13
pOCT4 Distal
3.21 + 0.99
7.34 + 2.01
pNanog Proximal
1.40 + 0.77
0.86 + 0.84
pNanog Distal
0.26 + 0.18
0.06 + 0.03
p = Porcine.
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Figure 5.5 Proximal and Distal Promoter Regions of Oct-4 and Nanog. Primers were designed
for regions proximal and distal to the initiation of transcription (shown in green). ChIP procedure
was performed for immunoprecipitated chromatin containing the H3K4me3 and H3K27me3
modifications and real-time PCR was performed to determine the presence of the modifications
within the promoter regions of Oct-4 and Nanog. Transcripts were run on an electrophoresis gel
for visualization.
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proportion of the input chromatin, and 31.81 + 6.13 for the H3K27me3 epigenetic mark. The
Oct-4 distal promoter region generated lower values of 3.21 + 0.99 for lysine 4 and 7.34 + 2.01
for lysine 27. Nanog proximal (1.40 + 0.77 and 0.86 + 0.84) and distal (0.26 + 0.18 and 0.06 +
0.03) promoters generated low values for each modification lysine 4 and lysine 27, respectively.
Discussion
Over a decade after the successful production of the first viable cloned sheep offspring
named Dolly (Wilmut et al., 1997), the efficiency of NT remains remarkably low resulting in
approximately 1 to 2% live births (Hiendleder et al., 2005). Research initially focused on factors
surrounding crucial synchronization of the cell cycle phase of the donor nucleus and the
recipient cytoplasm, but has shifted to investigate the mechanisms involved in adequate
reprogramming of the donor genome.
During normal mammalian development, periods of genome-wide reprogramming of
epigenetic patterns are believed to occur. The events following fertilization of the oocyte
generate many different types of cells that make up the developing organism. A distinguishing
pattern of epigenetic mechanisms summons differential subsets of gene activities without
altering the DNA sequence. Resultant epigenetic modifications, including histone modifications
and DNA methylation, direct the cells produced from the fertilized oocyte to differentiate into a
specialized cell type or tissue. The sophisticated genetic coordination regulates proper
temporal and spatial expression of these genes throughout development (Lieb et al., 2006;
Shiota, 2004).
The procession of these events must be preceded by the removal of acquired epigenetic
modifications instated by genetic predisposition or environment in germ cells for normal
development and donor cells for NT (Allen et al., 1990; Engler et al., 1991; Reik et al., 1993;
Sapienza et al., 1989). The failure of NT embryos to develop normally may be attributed to
inherited epigenetic information from the somatic donor cell by the embryo as a result of
incomplete erasure of the donor genome (Santos and Dean, 2004). Therefore, the use of a cell
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such as a stem cell with low or absent levels of chromatin remodeling proteins such as Dnmt1,
Dnmt3a, HDAC1 and MeCP2 may correlate to low levels of DNA methylation translating into
more complete reprogramming in NT embryos. In this study, the gene expression profiles of
epigenetic factors and their resultant modifications in differentiated fetal porcine fibroblasts
(FPF) and undifferentiated porcine adipose tissue-derived stem cells (pASCs) at multiple
passages through in vitro culture.
The current techniques employed today to establish and maintain primary in vitro cell
cultures may be responsible for the induction of cytokinetic abnormalities and chromosomal
alterations (Chu, 1962; Denning et al., 2001; Kasinathan et al., 2001; Oback and Wells, 2002;
Rubin, 1997). We observed marked changes in the levels of mRNA for the chromatin
remodeling proteins analyzed through culture in both FPFs and pASCs. However, the variation
was much more substantial in the FPF cell lines when compared to the pASC cell lines. None
of the cell lines analyzed were frozen at any point in the study; therefore neither the effects of
cryoprotectants nor the freezing procedure itself can be responsible for the observed changes in
transcript expression. However, the cellular stresses induced during the initial establishment of
the cell cultures especially in FPFs most likely attributed to the variation of mRNA expression
levels as well as the high levels of both DNA methylation and histone acetylation in the analysis
of passage 1 cell lines. Spontaneous transformations reported to accumulate proportionally to
the time in culture (Oback and Wells, 2002) may also contribute to the noted changes over time
in in vitro culture.
Dnmt1 directly interacts with MeCP2 to recognize hemi-methylated DNA while HDAC1
works with both Dnmt1 and MeCP2 to deacetylate histones (Nan et al., 1998). As a unit these
proteins function to maintain DNA methylation over multiple generations in culture (Kimura and
Shiota, 2003) forming a synergism between histone acetylation and DNA methylation. In
addition, Dnmt3a will also function as a maintenance enzyme since a knockout demonstrates a
decreased level of DNA methylation over time in culture (Chen et al., 2003). Therefore, DNA
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methylation would be expected to increase in response to an increase in the prevalence of
these three proteins.
In this study, the messenger RNA pattern detected in pASCs for Dnmt1, Dnmt3a,
HDAC1 and MeCP2 all followed the same pattern through culture with a noted increase in
expression at passage 3 followed by a subsequent decrease through passage 9. A possible
explanation of the increase in the expression levels of these proteins at passage 3 may be that
the during the first two passages the cells are battling the initial stress of establishing the culture
and that by passage 3 the cells have reinstated normal cellular processes. Nevertheless,
expression levels of these proteins through in vitro culture remain low and correlate to the
expected low level of methylated DNA during passages 2 through 7. Interestingly, the low level
of DNA methylation for pASCs remained consistently low over passages 2 through 7, which was
not observed to be true for FPF cell lines similar to those currently employed for NT. This
finding suggests that pASCs may serve as more efficient donor cells for NT because a lower
level of DNA methylation may be more easily reprogrammed following fusion with the
enucleated oocyte.
The expression levels of HDAC1 in pASCs and FPFs were also observed at relatively
low levels throughout culture. The low abundance parallels the lower levels found for the other
three chromatin remodeling proteins. In relation to the expression levels of the HDAC1
transcript, histone H3 acetylation patterns in pASCs were relatively low from passage 3 through
passage 7. This trend roughly correlates to the observed low levels of DNA methylation at
passages 2 through 7.
Primary cells utilized to establish culture possess the capacity to survive only a finite
number of population doublings before cellular senescence is reached (Hayflick and Moorhead,
1961). As cells approach this limit, the rate of proliferation decreases (Cameron, 1972) and the
probability of cells to undergo cytokinetic abnormalities and chromosomal alterations increases
substantially (Giraldo et al., 2006; Oback and Wells, 2002). We observed an altered display of
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DNA methylation and histone H3 acetylation in the initial cultures as well as the late passage 9
in pASCs. The variation at these time points in culture may be attributed to the establishment of
the cell culture in vitro for the first few passages and the accumulation of chromosomal
abnormalities for the late passage 9 cell populations. FPF cell lines also exhibited a high
degree of variation in DNA methylation and histone H3 acetylation through culture. These
findings are consistent with the pattern of epigenetic modifications detected in bovine fetal
fibroblasts (Giraldo et al., 2007). The presence of a heterogenous cell population, a greater
susceptibility to spontaneous transformation or characteristics exclusive to the particular cell line
may be potential culprits of the variation.
The inconsistent patterns of DNA methylation and histone acetylation found in FPF cell
lines are probably more likely than pASCs to induce higher methylation levels found in cloned
embryos. A study using bovine fibroblasts showed that although bovine fibroblast nuclei initially
lost some methylation following fusion with the oocyte, further demethylation was not observed
and instead de novo methyltrasnferases prematurely reinstated levels back to resemble that in
differentiated nuclei (Dean et al., 2001). Somatic cell-like methylation patterns found in cloned
embryos such as these may be a result of the introduction of the somatic version of Dnmt1 upon
fusion with the recipient oocyte, which functions to maintain methylation patterns characteristic
to the cell type in which it was derived (Reik et al., 2001). Thus a requirement for successful NT
is the sufficient erasure of inherited epigenetic information from the differentiated donor cell
nuclei.
In conclusion, in vitro cultured cells demonstrated altered mRNA transcript levels of
chromatin remodeling proteins, which were consistently lower in pASCs than in FPFs. Also,
FPF cell lines displayed greater variability in DNA methylation and histone H3 acetylation
patterns than pASCs. We suggest that cultured pASCs, which display a consistently lower DNA
methylation pattern as we described, may be more conducive to proper reprogramming
necessary for improved efficiency of NT. Also, preliminary evidence suggests the presence of a
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stem cell-associated bivalent chromatin structure harboring both H3K4me3 and H3K27me3
epigenetic modifications within the promoter region of Oct-4, providing further evidence that
these cells possess this stem cell characteristic. Subsequent employment of these cells in NT
procedures will elucidate the true efficacy of pASCs as donor cells for NT.
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CHAPTER VI
SUMMARY AND CONCLUSIONS
Although considerable amounts of research have focused on the intricacies involved in
the process of NT, the efficiency of the procedure remains low with a 1 to 2% success rate. In
addition to the low efficiency, anomalies resulting from suboptimal NT ultimately jeopardize the
health and welfare of any produced cloned offspring generating problems such as those
symptoms associated with Large Offspring Syndrome. Research has previously focused on
factors such as the improper synchrony of the cell cycle phase of the donor cell nucleus with the
recipient ooplasm and more recently has shifted to investigating adequate reprogramming of the
donor genome.
The failure of NT embryos to develop normally may be attributed to inherited epigenetic
information from the somatic donor cell by the embryo as a result of incomplete erasure of the
donor genome. Therefore, the use of a cell such as a stem cell with low or absent levels of the
enzymes responsible for creating the epigenetic landscape such as Dnmt1, Dnmt3a, HDAC1
and MeCP2 may correlate to a lower incidence of inherited epigenetic marks carried over from
the cell type in which the donor cell was derived. The incorporation of a donor cell with low
levels of DNA methylation initially may ultimately translate into more complete reprogramming in
NT embryos.
Research in stem cell biology has exploded over the last two decades. However, the
basic biology of in vitro culture continues to be elucidated. The improvement of culture
conditions and the definition of cellular characteristics will aid the efficient isolation and
purification of stem cell populations from multiple species-specific tissues creating important
animal models for biomedical applications. Specific to this project, current knowledge of the
optimal culture conditions for pluripotent and differentiated MSCs from adipose tissue, an easily
attainable tissue source have not been defined. Also, culture characteristics of these cells have
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not been clearly defined and studies generating gene and protein expression profiles are
underway, but remain inconclusive.
Stem cell characteristics must be clearly defined in order to isolate, identify and optimally
culture potential donor cells for NT. Stem cell characteristics such as self-renewal and
differentiation have not been identified until now in stem cells from porcine adipose tissue. In
addition, the phenotypic profile of cell surface proteins and chromosomal stability of porcine
adipose tissue-derived stem cells (pASCs) through in vitro culture has not been described. At
this time, research has not identified epigenetic modifications in adult somatic MSCs from
porcine adipose tissue.
In Project 1 we developed a successful protocol for the isolation and culture of pASCs
and determined stem cell-like characteristics. Initial culture of pASCs generated similar
quantities of cells to those of other species-specific fat depots reported in the literature. pASC
cell cultures preferred a higher seeding density in order for rapid colony cultivation to ensue.
The duration of culture pASCs can undergo without reaching replicative senescence was
comparable to those published for human adipose tissue and porcine bone marrow aspirates
and the cell cycle lengths although a little longer for pASCs were also very similar to other
species-specific tissues.
The cloning capacity of pASCs was determined using a ring cloning procedure. Multiple
colonies were identified establishing the ability of pASCs to self-renew. The colonies were then
subjected to differentiation conditions and found to differentiate successfully into osteogenic,
adipogenic and chondrogenic tissue lineages.
Continuing our investigation of the basic biology of pASCs in Project 2, we described the
cell surface profile for stem cell associated surface markers comparing early and late passages
of undifferentiated porcine ASCs. The surface phenotype of porcine ASCs is similar for some
stem cell antigens and different for others when compared with human ASCs cell surface, as
reported in the literature. Different from reported values for human ASCs, porcine ASCs did not
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demonstrate positive expression for CD44 or SSEA-4. We confirmed the absence of CD44 by
western blot analysis. It is important to note that Project 1 was extracted from our publication
that included a study, which did, in fact, reveal positive gene expression of CD44 though
reverse transcriptase polymerase chain reaction. SSEA-4, found on bone marrow MSCs and
human ASCs, and Sca-1, also found on MSCs, were not detected on the surface of porcine
ASCs at early or late PDs. We did find consistent with the literature, however, CD29 and CD90
expression detected in early and late PDs while CD8 and CD117 antigens were not present at
early or late PDs. Our study is by no means a comprehensive investigation for stem cell
markers potentially present on the surface of porcine ASCs and many others will need to be
analyzed as antibodies become available.
The chromosomal stability of pASCs through in vitro culture was found to be similar to
bovine fetal fibroblasts as published in the literature. pASCs demonstrated an increased
percentage of aneuploid cells directly from the initiation of culture with almost a 50% decrease
in the incidence of normal diploid cells. The percentage of aneuploid cells significantly
increased for middle PDs and late PDs. The assault to chromosomal stability clearly occurs
after removing the cells from their in vivo environment, which is supported by such elevated
levels of aneuploidy directly from the start in both bovine fetal fibroblasts and porcine ASCs.
The sub-optimal culture conditions continue to corrode the genetic stability of the cells as they
fight to survive in vitro culture through middle and late PDs as indicated by the significant
increases in aneuploidy.
In Project 3, we analyzed the gene expression profiles of epigenetic factors and their
resultant modifications, DNA methylation and histone H3 acetylation, in differentiated FPF and
undifferentiated pASCs at multiple passages through in vitro culture. We observed marked
changes in the levels of mRNA for the chromatin remodeling proteins analyzed through culture
in both FPFs and pASCs. However, the variation was much more substantial in the FPF cell
lines when compared with the pASC cell lines. The messenger RNA pattern detected in pASCs
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for Dnmt1, Dnmt3a, HDAC1 and MeCP2 all followed the same pattern through culture and
remained low, which correlates with the expected low level of methylated DNA observed during
passages 2 through 7. Interestingly, the observed low level of DNA methylation for pASCs
remained consistently low over passages 2 through 7, which was not true for FPF cell lines
similar to those currently employed for NT. In relation to the expression levels of HDAC1,
histone H3 acetylation patterns in pASCs were relatively low from passage 3 through passage
7. This trend roughly correlates to the observed low levels of DNA methylation at passages 2
through 7. Also, we observed an altered display of DNA methylation and histone H3 acetylation
in the initial cultures as well as the late passage 9 in pASCs. FPF cell lines also exhibited a
high degree of variation in DNA methylation and histone H3 acetylation through culture.
We consider the possibilities of cellular stresses induced during the initial establishment
of the cell cultures especially in FPFs and spontaneous transformations reported to accumulate
proportionally to the time in culture as culprits to the variation of mRNA expression levels as well
as the high levels of both DNA methylation and histone acetylation in the analysis of passage 1
cell lines. Also, the variation at initial culture and later in passage may be attributed to the initial
events necessary to establishment cell culture and the accumulation of chromosomal
abnormalities in later passages. The presence of a heterogeneous cell population, a greater
susceptibility to spontaneous transformation or unique characteristics to the cell line under
investiation may also be attributed with the variation noted in our results.
In conclusion, improved culture conditions and defined cellular characteristics of selfrenewal of these pASCs have been identified. pASCs can self-renew and differentiate into
multiple tissue lineages. The phenotypic landscape of pASCs is similar for some cell surface
markers reported in human ASCs and different for others. In vitro cultured porcine ASCs used
as donor cells for NT should be chosen from early PDs due to increased levels of aneuploidy at
later PDs. pASCs may serve as more efficient donor cells for NT because a lower level of DNA
methylation may be more easily reprogrammed following fusion with the enucleated oocyte. It is
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suggested that cultured pASCs which display a consistently lower DNA methylation pattern as
we described may be more conducive to proper reprogramming necessary for improved
efficiency of NT. Subsequent employment of these cells in NT procedures will elucidate the true
efficacy of pASCs as donor cells for NT.
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APPENDIX A: PROTOCOLS
WESTERN BLOTTING PROTOCOL
1. Place 2-10% gels in running buffer.
2. Load Gels:
a. Load using 1:1 ratio of loading buffer:sample
b. 10 !l MW stds –heat in water bath
c. Heat samples at 95°C for 5-10 minutes
3. Run gels at 100 V until standards reach the bottom of the gel (~1 " hour-3 hours).
4. Wash gel for coomassie stain in MQ Water 3 X for 5 minutes.
5. Stain gel in Coomassie Blue (Bio-Rad Catalog # 161-0786).
6. Equilibrate gel by transferring into cold transfer (Towbin’s) buffer (> 15 min).
7. Prepare membrane 30 seconds in 100% Methanol.
8. Transfer membrane into cold Towbin’s buffer 2-3 minutes.
9. Soak pads and filter paper in cold transfer buffer.
10. Prepare transfer sandwich (load on black side of gel holder cassette in order):
a. Pad
b. Filter paper
c. Gel
d. Membrane
e. Filter paper
f. Pad
11. Place red and black mini trans-blot module into gel tank with the black side in the center
and banana plugs in middle.
12. Place the frozen ice block (frozen in -80ºC) into gel tank.
13. Slide cassette into the red and black mini trans-blot module as follows:
a. Black side of the sandwich facing the black side of the mini trans-blot module
(middle) and clear side facing the red (outside).
14. Fill tank with cold Towbin’s buffer and a stir bar and place in ice bucket.
15. Place ice bucket on stir plate and pack ice around the transfer apparatus.
16. Run transfer at 90 volts for about 90 minutes (make sure bubbles appear between transblot module and ice block).
17. Remove cassette, disassemble, and place membrane in blocking buffer 2 to 3 hours
(poke holes to denote where to cut membrane if probing with different antibodies).
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18. Pour off blocking buffer and incubate with 1° Antibody according to predetermined
dilution (1:2000) overnite at 4ºC:
a. 20 ml of Blocking buffer
b. 10 !l primary antibody
19. Perform 5 X 10 minute washes in TBST.
20. Incubate with 2° Antibody according to predetermined dilution (1:3000) for 1 hour at
room temperature:
a. 20 ml of Blocking buffer
b. 6.7 !l secondary antibody
21. Perform 5 X 10 minute washes in TBST.
22. Incubate in color reagents for 30 minutes or when color appears:
a. 1 x HRP = 20 ml
b. Bio-Rad Reagent A = 2 ml
c. Bio-Rad Reagent B = 120 !l
Alternatively,
23. a. Mix ECL reagents 1:1 and allow to warm to room temperature.
b. Blot off wash buffer onto a paper towel by capillary action.
c. Place membrane on a piece of saran wrap.
d. Apply ECL reagents to top of membrane allowing surface tension to hold volume.
e. Incubate for 1 minute.
f.

Again blot off ECL reagents onto a paper towel by capillary action.

g. Place protein side down onto another piece of saran wrap and fold into a pocket.
h. Tape into film cassette and expose to xray film 2 minutes, 5 minutes, 20 to 30
minutes, overnite.
i. Develop film in dark room.
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CHROMATIN IMMUNOPRECIPITATION PROTOCOL
DNA-protein Cross-linking, Cell Lysis and Chromatin Fragmentation:
1. Harvest cells by trypsinization per standard protocol.
2. Count cells and allocate 2.5 x 106 cells to ChIP.
3. Centrifuge cells 300 x g for 5 minutes and remove supernatant.
4. Resuspend cells in 515 µl PBS (without calcium).
5. Add 34 µl of 16% paraformaldehyde (gives 1% v/v) and vortex lightly.
6. Incubate at room temperature 8 minutes.
7. Add 62 µl room temperature 10X glycine (final concentration 125 mM).
8. Incubate at room temperature 5 minutes.
9. Centrifuge cells 300 x g for 10 minutes at 4°C and remove supernatant.
10. Wash in 500 µl PBS.
11. Centrifuge cells 300 x g for 10 minutes at 4°C and remove supernatant.
12. Repeat wash (steps 10 and 11) or alternatively flash freeze pellet in LN2 and store at 80°C.
13. Resuspend in 500 µl Lysis Buffer and vortex lightly.
14. Incubate on ice for 5 minutes.
15. Transport cells to sonicate.
16. Sonicate each sample on Branson Sonifier 250 Duty cycle 40% Level 4 for 10 x 20
pulses on ice with 1 minute pause in between each set of 20 pulses.
17. Centrifuge at 12,000 x g for 10 minutes at 4°C.
18. Remove supernatant and put in new tube.
19. Can store at -80°C or move on to next procedure.
Preparation of Antibody-Bead Complexes:
1. For each sample to be analyzed, remove 11 µl well-suspended bead stock solution
(Millipore MagnaChIP Kit, Catalog #MAGNA001).
2. Place single tube in magnet to capture beads and remove storage buffer.
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3. Remove tube from magnet and resuspend beads in 500 µl RIPa buffer.
4. Mix lightly and replace into magnet to capture beads and remove RIPA buffer.
5. Repeat wash (steps 2-4).
6. Resuspend beads in 10.5 µl RIPA buffer for each sample (i.e., 10.5 x # samples gives
total volume to resuspend with).
7.

Add 90 µl RIPA buffer to 0.2 ml PCR tube (1 per sample).

8. Add 10 µl pre-washed beads to each PCR tube and 2.4 µg of antibody.
9. Incubate at 4°C for 2 hours at 40 rpm on VWR Hybridization Oven.
Immunoprecipitation:
1. Dilute chromatin to 3 ml with RIPA buffer supplemented with 30 µl HALT protease
inhibitor (approximately 100,000 cells in 100 µl).
2. Make 100 µl aliquots and store in -20°C.
3. Touch-spin PCR tubes containing antibody-bead complexes to remove contents from lid.
4. Place into ice-cold magnet to capture beads and remove RIPA buffer.
5. Remove tubes from magnet and resuspend in 100 µl of aliquoted chromatin.
6. Incubate at 4°C overnight at 40 rpm on VWR Hybridization Oven.
7. Touch-spin PCR tubes, place in ice-cold magnet and remove RIPA buffer.
8. Remove tubes from magnet and resuspend in 100 µl RIPA buffer.
9. Incubate at 4°C for 4 minutes at 40 rpm on VWR Hybridization Oven.
10. Repeat wash 2 times (steps 7-9).
11. Touch-spin PCR tubes, place in ice-cold magnet and remove RIPA buffer.
12. Resuspend beads in 100 µl TE buffer.
13. Incubate at 4°C for 4 minutes at 40 rpm on VWR Hybridization Oven.
14. Touch-spin PCR tubes and transfer contents to new PCR tube.
15. Place on magnet to capture beads and remove TE buffer.
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DNA Elution, Cross-link reversal and Proteinase K Digestion:
1. Add 150 µl Elution buffer and add SDS to 1% and proteinase K to 50 µg/ml.
2. Add 200 µl Elution buffer to another 100 µl aliquot of diluted chromatin and add
proteinase K to 50 µg/ml.
3. Incubate at 68°C for 2 hours at 40 rpm on VWR Hybridization Oven.
4. Touch-spin tubes and place on magnet to capture beads.
5. Collect supernatant and transfer to new 1.5 ml tube.
6. Add 150 µl Elution buffer/SDS/proteinase K and resuspend beads.
7. Incubate at 68°C for 5 minutes at 40 rpm on VWR Hybridization Oven.
8. Touch-spin tuves and place on magnet to capture beads.
9. Collect supernatant and add to 1.5 ml tube.
DNA Isolation:
1. Add 500 µl Bind Reagent A (Millipore Kit) to each sample and vortex.
2. Transfer sample/Bind Reagent A to Spin filter in collection tube.
3. Centrifuge for 30 seconds at 12,500 x g.
4. Remove spin filter from collection tube and save collection tube while discarding liquid.
5. Replace spin filter into collection tube and add 500 µl Wash Reagent B.
6.

Centrifuge for 30 seconds at 12,500 x g.

7. Remove spin filter from collection tube and save collection tube while discarding liquid.
8. Replace spin filter into collection tube.
9. Centrifuge for 30 seconds at 12,500 x g.
10. Discard collection tube containing residual liquid.
11. Place spin filter into new collection tube.
12. Add 130 µl Elution Buffer C directly onto center of white spin filter membrane.
13. Centrifuge for 30 seconds at 12,500 x g.
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14. Remove spin filter and discard.

15. Analyze purified DNA by qPCR or store at -20°C.
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TRI REAGENT® RNA ISOLATION PROTOCOL
1. Turn on centrifuge and let cool to 4° C.
2. Prep phase lock tubes by spinning at 3500 x g for 10 minutes.
3. Pour off medium from flasks.
4. For T75 add 8 ml Trizol reagent to each T75 flask and pass cell lysate through pipette
several times. Incubate at room temperature 5 min knock on counter top to dissociate.
5. Use the scrapper to remove cells and transfer lysate to phase lock tube.
6. Incubate at room temperature 5 minutes to permit the complete dissociation of
nucleoprotein complexes.
7. Add 0.8 ml BCP in hood.
8. Cap tubes and shake vigorously by hand for 15 to 30 seconds.
9. Incubate tubes at room temperature for 30 minutes to 1 hour.
10. Centrifuge at 12,000 g for 15 minutes at 4° C.
11. Transfer aqueous supernatant into a fresh tube.
12. Precipitate RNA by mixing with 4 ml isopropyl alcohol (for T75). Shake well.
13. Hold at -20° C overnite for optimal recovery.
14. Centrifuge at 12,000 g for 20 minutes at 4° C putting number side up. RNA will form a
gel-like or white pellet on the side and bottom of the tube.
15. Pour off supernatant away from pellet.
16. Respin pellet at 12,000 g for 2 minutes at 4° C.
17. Wash the RNA pellet in 75% EtOH (prepared in DECP water) using at least 1 ml of
EtOH per 1 ml of Trizol reagent (8 ml for T75—make 40 ml for 4 samples).
18. Vortex tube until pellet is floating. Can use pipette tip to push off sides.
19. Centrifuge at 15,000 g for 10 minutes.
20. Transfer pellet in 1 ml ethanol (left from previous step) and respin for 15 minutes in 1.5
ml tube.
21. Carefully remove ethanol supernatant with a pipette followed by a disposable pipette
then a thirsty stick.
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22. Briefly dry the RNA pellet with top off at 37° C for about 7 minutes.
23. Dissolve the RNA pellet in DEPC water about 25 ul and incubate in 55 to 60° C
waterbath about 10 minutes if needed.
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KARYOTYPING PROTOCOL
1. Thaw or passage cells 24 hours prior to cell synchronization.
2. Add 0.05 µg/ml of KaryoMax® to directly to cell culture.
3. Incubate 30 minutes to 3 h at 37°C.
4. Remove media and put to side.
5. Harvest cells by trypsinization.
6. Add harvested cells to medium from step 4.
7. Centrifuge at 1200 x g for 5 minutes.
8. Remove supernatant and SLOWLY resuspend cells in 3 ml pre-warmed hypotonic
solution in 0.5 ml increments.
9. Incubate in 37°C water bath 5 minutes.
10. Centrifuge at 1200 x g for 5 minutes.
11. Remove supernatant.
12. SLOWLY add fixative (3:1) in 0.5 ml increments.
13. Incubate in 4°C for 10 minutes.
14. Centrifuge at 1200 x g for 5 minutes.
15. Remove supernatant.
16. Resuspend in 0.5 ml fresh fixative.
17. Store in -20°C at least overnight and up to 2 months.
18. Hold clean slide at an angle and place 3 to 5 10 µl drops of cell suspension and
allow drops to spread down slide.
19. Allow slides to dry at least 10 minutes.
20. Flood slide with 4 x 1 ml of 1:1 fixative.
21. Allow slides to dry at least 10 minutes.
22. Drop slides into Giemsa stain for 15 minutes.
23. Remove slides from stain and gently rinse with deionized water.
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24. Allow slides to dry completely.

25. Visualize under 100 X oil immersion.
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APPENDIX B: REAGENT FORMULATIONS

REAGENT
10X Tris/Glycine/SDS

WESTERN RUNNING BUFFER
CATALOG
COMPANY
NUMBER
BIO-RAD

161-0732

MQ Water

AMOUNT
100 ml
900 ml

Prepare on day of use.

REAGENT
Laemmli buffer
beta-mercaptoethanol

WESTERN LOADING BUFFER
CATALOG
COMPANY
NUMBER

AMOUNT

BIO-RAD

161-0737

950 !l

Sigma

M-7522

50 !l

Prepare on day of use.

REAGENT

WESTERN TOWBIN’S BUFFER
CATALOG
COMPANY
NUMBER

AMOUNT

Trizma-Base

Sigma

T-1503

3.03 g (25 mM)

Glycine

Sigma

G-8898

14.4 g (192 M)

Methanol

Sigma

M-1775

200 ml (20 %)

MQ Water
Prepare on day of use.

Bring up to 1 L
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REAGENT

WESTERN TBST BUFFER
CATALOG
COMPANY
NUMBER

AMOUNT

10X TBS

BIO-RAD

170-6435

100 ml

10% Tween 20

BIO-RAD

161-0781

5 ml

MQ Water
Prepare on day of use.

REAGENT
Non-fat Dry Milk

Bring up to 1 L

WESTERN BLOCKING BUFFER
CATALOG
COMPANY
NUMBER
BIO-RAD

170-6404

TBST
Prepare on day of use.

AMOUNT
10 g
200 ml

ChIP LYSIS BUFFER
CATALOG
COMPANY
NUMBER

REAGENT

AMOUNT

Trizma-HCl

Fluka

93313

5 ml (50 mM)

EDTA

Sigma

E7889

2 ml (10 mM)

10% SDS

Gibco

15553-035

Thermo-Scientific

1860932

HALT Proteases Inhibitor

PMSF
Store at 4°C several months.

Sigma
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10 ml (1 %)
100 µl
5 µl (1 mM)

ChP RIPA BUFFER
COMPANY

CATALOG
NUMBER

AMOUNT

Trizma-HCl

Fluka

93313

1 ml (10 mM)

EDTA

Sigma

E7889

200 µl (1 mM)

EGTA

Sigma

E3889

50 ml (0.5 mM)

Triton X-100

Sigma

X-100

1 ml

10% SDS

Gibco

15553-035

1 ml (0.1 %)

Sodium deoxycholate

Sigma

D6750

0.1 g

NaCl

Sigma

S5886

0.818 g

REAGENT

MQ Water
Store at 4°C several months.

REAGENT
Trizma-HCl

Bring to 100 ml

ChIP TE BUFFER
CATALOG
COMPANY
NUMBER
Fluka

EDTA
Sigma
Store at room temperature several months.

REAGENT

AMOUNT

93313

250 µl (10 mM)

E7889

500 µl (10 mM)

ChIP Elution BUFFER
CATALOG
COMPANY
NUMBER

AMOUNT

Trizma-HCl

Fluka

93313

500 µl (20 mM)

EDTA

Sigma

E7889

250 µl (5 mM)

NaCl

Sigma

S5886

0.073 g

MQ Water
Store at room temperature several months.
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Bring up to 25 ml

REAGENT
DEPC

DEPC WATER
CATALOG
COMPANY
NUMBER
Sigma

D5758

MQ Water
Incubate at 37°C 1 hr, autoclave 15 min.
Store at room temperature several months.

REAGENT
Sodium Citrate

S4641

MQ Water
Filter and store at room temperature indefinitely.

REAGENT
Methanol

100 µl
100 ml

HYPOTONIC SOLUTION
CATALOG
COMPANY
NUMBER
Sigma

AMOUNT

AMOUNT
0.9 g
100 ml

3:1 FIXATIVE SOLUTION
CATALOG
COMPANY
NUMBER

AMOUNT

Sigma

M1775

15 ml

Acetic Acid
Sigma
Prepare fresh on day of use.

A6283

5 ml
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REAGENT

1:1 FIXATIVE SOLUTION
CATALOG
COMPANY
NUMBER

Methanol

AMOUNT

Sigma

M1775

10 ml

Acetic Acid
Sigma
Prepare fresh on day of use.

A6283

10 ml

REAGENT

GIEMSA STAINING SOLUTION
CATALOG
COMPANY
NUMBER

Giemsa Stain

Sigma

GS-500

MQ Water
Prepare fresh on day of use.

AMOUNT
2 ml
28 ml
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